Endogenous Synthesis of Glycine  from Hydroxyproline in Neonatal Pigs by Hu, Shengdi
  
 
 
ENDOGENOUS SYNTHESIS OF GLYCINE  
FROM HYDROXYPROLINE IN NEONATAL PIGS 
 
A Dissertation 
by 
SHENGDI HU  
 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
Chair of Committee,  Guoyao Wu 
Committee Members, Fuller W. Bazer 
 Yanan Tian 
 Annie Newell-Fugate 
Head of Department, G. Cliff Lamb 
 
December 2017 
 
Major Subject: Animal Science 
 
Copyright 2017 Shengdi Hu
 ii 
 
ABSTRACT 
 
This study was conducted to test the hypothesis that hydroxyproline is a novel and 
major substrate for endogenous synthesis of glycine in sow-reared pigs. At 0, 7, 14, and 
21 days of age, neonatal piglets with a normal or low birth weight (BW) were sacrificed, 
and their tissue samples were obtained for metabolic studies, activities of glycine-synthetic 
enzymes, mRNA expression, and the localization of proteins for those enzymes. 
Moreover, normal and IUGR piglets received oral administration of glycine (0.2, 0.4, and 
0.8 g/kg BW) between days 0 and 14 to evaluate a role for endogenous synthesis of glycine 
in the growth of piglets. 
Results from the studies of normal birth-weight piglets demonstrated that the activities 
of hydroxyproline oxidase (OH-POX), proline oxidase (POX), alanine:glyoxylate 
transaminase (AGT), and 4-hydroxy-2-oxoglutarate aldolase (HOA), key enzymes for 
glycine synthesis from hydroxyproline, decreased in the liver and kidneys between 
postnatal day 0 and day 21, but increased in the pancreas and small intestine over the same 
period of time (P < 0.05). Similar results were obtained for expression of mRNAs for those 
enzymes. The enzymatic activities and expression of mRNAs for serine hydroxymethyl 
transferase (SHMT) and threonine dehydrogenase (TDH) increased between days 0 and 
21 of age in most tissues (P < 0.05). Localization of OH-POX and POX shifted from 
periportal to perivenous hepatocytes in the liver as the animal grew. Tissues incubated 
with 0 to 5 mM hydroxyproline synthesized glycine in a concentration-dependent manner, 
but the conversion of glycine into serine was limited. The activities of OH-POX and 
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SHMT were lower in tissues of IUGR piglets (P < 0.05), compared with normal pigs. The 
activity of TDH did not differ between IUGR and normal piglets. Similar results were 
obtained for expression of mRNAs of those enzymes.  
Oral administration of glycine to sow-reared IUGR and normal birth-weight piglets 
enhanced the concentrations of glycine and serine in plasma, as well as weight gain (P < 
0.05), with the dose of 0.4 g glycine/kg BW being the most effective. Consistent with its 
growth-promoting effect, glycine supplementation augmented the phosphorylation of 
mechanistic target of rapamycin (MTOR), eukaryotic initiation factor 4E binding protein 
1 (4E-BP1) and p70S6 kinase (p70S6K) in skeletal muscle, compared with control piglets.  
The results of this research indicate that: (1) hydroxyproline, an abundant metabolite 
in sow’s milk and a product of collagen degradation, is a more important substrate for 
glycine synthesis in tissues of young pigs than serine and threonine; (2) endogenous 
synthesis of glycine is insufficient for maximal growth of sow-reared  IUGR and normal 
birth-weight piglets; and (3) glycine supplementation enhanced activity of the MTOR 
signaling pathway in skeletal muscle and growth performance of newborn piglets, 
especially those with a low birth weight. Collectively, these results indicate an important 
role for glycine in improving growth of and protein accretion in neonatal pigs.  
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NOMENCLATURE 
 
4E-BP1 4E binding protein 1 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Introduction 
As important compounds in humans and animals, amino acids serve numerous 
physiological functions (Wu et al. 2014). Only 20 of amino acids are building blocks for 
more than 700 cellular proteins. These 20 proteinogenic amino acids are: alanine, arginine, 
asparagine, aspartate, cysteine, glutamate, glutamine, glycine, histidine, isoleucine, 
leucine, lysine, methionine, phenylalanine, proline, serine, tyrosine, threonine, tryptophan, 
and valine. They have different side chains and chemical properties (Broer and Broer 
2017; Wu 2013b). Other amino acids also participate in vital physiological functions 
including detoxification of ammonia through the urea cycle, and synthesis of polyamines 
and nitric oxide. Thus, exploring the frontier of knowledge of amino acid biochemistry 
and nutrition is critical for improving human and animal health. 
 Traditionally, based on nitrogen balance or growth of animals, nutritionists classified 
amino acids as nutritionally essential amino acids (EAAs) or non-essential amino acids 
(NEAAs). There is a rich history of studies on amino acid requirements in humans and 
other animals (Chung and Baker 1992; Kim et al. 2001; Millward 1997; Rose 1968; 
Simoni et al. 2002; Wu 2014). In the 1910s, T.B. Osborne and L.B. Mendel defined EAAs 
as “amino acids which cannot be manufactured de novo in the animal organism” (Osborne 
et al. 1917). Until the 1930s, based on results from a series of human and animal 
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experiments, W.C. Rose classified amino acids as EAAs or NEAAs based on the health 
status and body weight changes of human subjects consuming semi-purified diets lacking 
a specific amino acid (Rose 1968). In the late 1990s, D.H. Baker included the different 
ratios of amino acids to lysine (the ideal protein) in formulating diets for swine (Chung 
and Baker 1992; Kim et al. 2001). Neither NRC Swine Nutrition Requirements in 1998 
nor D.H. Baker recognized the nutritional requirement for NEAAs (Kim et al. 2001). 
Growing evidence shows that arginine, cysteine, glycine, proline, and tyrosine, previously 
categorized as NEAAs, are required by many species since the endogenous synthesis of 
those AAs cannot meet the needs for the maintenance, optimum growth, and health of 
animals (Kim and Wu 2004; Wang et al. 2014a; Wang et al. 2013a; Wu 2013c; Wu et al. 
2011; Wu et al. 2014; Wu et al. 2008; Wu et al. 1994). Recently, Wu (2013c) defined 
EAAs as amino acids whose carbon skeletons cannot be synthesized de novo or 
synthesized in amounts that are insufficient to meet the needs of animals for maintenance, 
growth, development, and health. Clearly, EAAs must be provided in diets to meet the 
nutritional requirements of mammals, birds, and fish (Wu 2013c). Nutritionally non-
essential amino acids were previously defined as amino acids which can be synthesized in 
an adequate amount to meet the needs of maintenance, optimum growth, and health of 
animals. However, requirements of NEAAs are affected by many factors, including 
species, age, physiological status, and health conditions. Amino acids which are 
insufficiently synthesized at a specific physiological stage or under certain environmental 
conditions are classified as conditionally essential amino acids (CEAA). Those include 
glycine in poultry and milk-fed piglets, arginine, glutamine and proline in gestating and 
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lactating mammals, and aspartate and glutamate in enterally fed rats (Kim and Wu 2004; 
Li et al. 2007; Marc Rhoads and Wu 2009; Shewchuk et al. 1997; Wang et al. 2014a; Wu 
2013b; Wu et al. 2008). 
Glycine, also known as aminoacetic acid, has the simplest chemical structure among 
amino acids in nature, and has no D- or L- chemical configuration since it lacks an 
asymmetric carbon (Hall 1998; Jackson 1991; Wang et al. 2013a). The long history of 
glycine research dates back to 1820 when it was first obtained from acid hydrolysates of 
protein (i.e., gelatin) by the French chemist H. Braconnot. Subsequently, glycine was 
isolated from gelatin and meat by using alkaline hydrolysis. Glycine derived its name from 
its sweet taste, because the Greek word "glykys" means sweet (Meister 1992).  
 Glycine is one of the most abundant amino acids in animal proteins, and comprises 
one-third of amino acids in collagen and elastin (Wang et al. 2013a; Wu et al. 1999). Of 
note, glycine is the most abundant amino acid in plasma of postnatal pigs (Wu 2013c). 
Traditionally, glycine was classified as a NEAA in mammals since it can be synthesized 
from serine, threonine, and choline (Chao et al. 1953; Shemin 1946; Soloway and Stetten 
1953; Tressel et al. 1986). However, the metabolic demand for glycine is considerable 
(Wang et al. 2013). The amount of endogenously synthesized glycine can meet, at most, 
only 50% of requirements for global protein synthesis (Gersovitz et al. 1980; Jackson 
1991; Yu et al. 1985). For example, in poultry, the rate of endogenous glycine synthesis 
is much lower than the rate of utilization (Jackson 1991). Thus, studies have shown that 
endogenous synthesis of glycine is insufficient for supporting optimal metabolic 
requirements in rats, chickens and turkeys, and young pigs (Jackson 1991; Melendez-
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Hevia and De Paz-Lugo 2008; Wang et al. 2014a; Wu et al. 2013). Lack of glycine can 
lead to long-term negative effects on the growth of animals and the health of their multiple 
organ systems, including the gastrointestinal (GI) tract disorders, oxidative stress, 
neurological damage, muscular dysfunction, and abnormal fetal development (Hernandes 
and Troncone 2009; Lewis et al. 2005; Li et al. 2016; Matilla et al. 2002; Wang et al. 
2014a; Wu et al. 1994). Taken together, glycine should be classified as a conditionally 
essential amino acid for mammals and birds (Wu 2013c).  
Glycine synthesis in animals 
Glycine synthesis from serine 
The serine-glycine pathway was the first pathway discovered for glycine biosynthesis. 
In 1946, D. Shemin found that serine could be rapidly converted into glycine, because 15N 
and 13C in serine were readily recovered in glycine (Shemin 1946). The conversion of 
serine into glycine is relatively simple since it is a one-step reaction. As shown in Figure 
1.1, this reaction is catalyzed by tetrahydrofolate (THF)-dependent serine hydroxymethyl 
transferase (SHMT).  
Serine + H4folate 
SHMT
⇔   Glycine + 5, 10˗methylene˗H4folate   
It is noteworthy that serine transfers one-carbon unit to tetrahydrofolate to form N5-
N10-methylene-tetrahydrofolate (meTHF) (Wu 2013b). During the last 50 years, serine 
was considered the main substrate for glycine synthesis in animals. However, this view 
was formulated due to the limited knowledge of amino acid biochemistry and limited 
analytical tools at that time.  
 5 
 
Serine hydroxymethyl transferase (SHMT) is a pyridoxal phosphate-dependent 
enzyme (Wang et al. 2013a). SHMT is located in both the mitochondria (mSHMT or 
SHMT2) and cytoplasm (cSHMT or SHMT1) of mammalian cells. For glycine synthesis, 
mSHMT is the primary enzyme in the cell, and the activity of mSHMT is much higher 
than that of cSHMT (Schirch and Peterson 1980). Narkewicz et al. (1996) reported that 
by eliminating mSHMT activity in Chinese hamster ovary (CHO) cells, glycine 
production decreased and serine accumulated (Narkewicz et al. 1996), which indicated 
that mSHMT is the major enzyme responsible for glycine synthesis. In contrast, cSHMT 
activity does not affect intracellular concentrations of glycine and serine. In those previous 
studies, alternative substrates for glycine synthesis were not examined. 
There is evidence that total SHMT activity is regulated by nutritional status, hormones, 
and health conditions in a cell- and tissue-specific manner (Burns and Jackson 1982; 
Sanborn et al. 1975; Snell 1984; Snell et al. 1988). For example, folate availability limits 
SHMT activity (Burns and Jackson 1982). Sanborn et al. (1975) reported that estradiol 
and testosterone increased serine metabolism in the uterus and prostate gland via 
enhancing SHMT activity (Sanborn et al. 1975). Additionally, SHMT activity is much 
higher in tumor cells than in non-tumor cells, which may indicate a high glycine 
requirement for cells during tumorigenesis (Snell et al. 1988). 
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Figure 1.1. Classic pathway for the endogenous synthesis of glycine in animals. Glycine may be 
synthesized from serine, threonine, and choline. The three pathways play multiple physiological functions 
other than glycine synthesis. The yellow part of the figure highlights the serine-glycine pathway, the blue 
part the threonine-glycine pathway, and the red part the choline-glycine pathway. AKB, 2-Amino-3-
ketobutyrate; α-KG, a-Ketoglutarate; SHMT, Serine hydroxymethyl transferase. Adapted and revised from 
Wang et al. (2013). 
 
Glycine synthesis from threonine 
For a long time, there was misidentification of the key enzyme that catalyzes the 
conversion of threonine into glycine. Schirch and Gross (1968) claimed that purified 
SHMT from rabbit liver not only catalyzed serine into glycine, but also cleaved threonine 
to glycine. Thus, threonine aldolase and SHMT were thought to be the same enzyme 
(Schirch and Gross 1968). However, subsequent work revealed that threonine aldolase is 
different from SHMT in bacteria and mammals. These two enzymes have different 
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functions and amino acid sequences, even though SHMT exhibits low threonine aldolase 
activity in rabbit liver (Bird and Nunn 1983; Dale 1978; Ogawa et al. 2000; Yeung 1986). 
There are two threonine-metabolic pathways: one requires threonine dehydrogenase and 
the other requires threonine aldolase. Both pathways can convert threonine into glycine, 
but the threonine dehydrogenase pathway accounts for most (more than 80%) degradation 
of threonine in animal livers (Bird and Nunn 1983; Davis and Austic 1994; Wu 2013a), 
but not all studies support this view. Darling et al. (2000) reported that the threonine 
dehydrogenase pathway played only a minor physiological role in adult humans (Darling 
et al. 2000). However, another study indicated that almost half of threonine degradation 
in newborn human infants occurs via the threonine dehydrogenase pathway (Parimi et al. 
2005). This contradiction may indicate an age-dependent change in the expression of 
threonine-catabolic enzymes.  
The major biochemical pathway for synthesis of glycine from threonine in the liver of 
animals requires two steps. In the first reaction, threonine and NAD+ are converted by 
TDH into 2-amino-3-ketobutyrate (AKB) and NADH. In the second reaction, AKB is 
converted into glycine by AKB-lyase (Darling et al. 2000; House et al. 2001; Wu 2013b). 
Overall, the net reaction is as follows: 
Threonine +  NAD+ + CoA
TDH & AKB lyase
⇒            Glycine + Acetyl˗CoA +  NADH + H+  
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Glycine synthesis from Choline 
Choline is a dietary ingredient in human and animal foods. The physiological functions 
of choline include one-carbon unit metabolism, cell membrane integrity, 
neurotransmission, and cell signaling, all of which are crucial for maintaining the normal 
function of cells (Zeisel 1981; Zeisel and Blusztajn 1994). The oxidative degradation of 
choline yields glycine via the formation of betaine (Soloway and Stetten 1953). 
Specifically, choline is oxidized to betaine by choline dehydrogenase and betaine aldehyde 
dehydrogenase in the mitochondria of liver and kidney cells (Zhang et al. 1992). Betaine 
transmethylase methylates betaine to form dimethylglycine. The latter is oxidized to 
sarcosine (N-methylglycine) by dimethylglycine oxidase. The sarcosine-glycine pathway 
occurs in a few tissues in animals and contributes to one-carbon unit metabolism 
(Bergeron et al. 1998; Yeo and Wagner 1994). The net reaction for glycine synthesis from 
choline is as follows: 
Choline +  NAD+ + 4O2 + 4 H2O
 enzymes
⇒      Glycine + 4H2O2 + 3HCHO +  NADH + H
+  
It should be born in mind that the contribution of choline to the synthesis of glycine is 
limited for two reasons. First, the amount of choline in both diet and physiological fluids 
is relatively low, compared to serine and threonine. Second, the choline-serine pathway is 
highly cell-specific and is utilized primarily for choline catabolism. Dietary choline is used 
mainly for the synthesis of phosphatidylcholine and sphingomyelin required for 
maintenance of cell membranes as) and for cholinergic neurotransmission (acetylcholine 
synthesis) (Wang et al. 2013a; Zeisel 1981).  
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Glycine facilitates inter-organ and intracellular transfer of methyl groups by bridging 
tetrahydrofolate (THF) and N5-N10-methylene-tetrahydrofolate (meTHF) in folate 
metabolism (Wu 2009; Wu 2013a; Wu 2013b). This is closely linked with the conversion 
of homocysteine (an oxidant) into methionine in the liver via S-adenosyl methionine 
(SAM)-dependent methylation (Finkelstein and Martin 2000).  
Glycine catabolism in animals  
Glycine catabolism through the glycine cleavage system 
The glycine cleavage system (GCS) is the major enzyme system responsible for 
glycine catabolism in animals. GCS is a conservative enzyme complex widely distributed 
from prokaryotes to vertebrates (Kikuchi et al. 2008; Lowry et al. 1985b). In animals, the 
GCS is localized in the mitochondrial inner membrane and plays critical roles in glycine 
metabolism (Jois et al. 1992; Wang et al. 2013a). 
Glycine +  NAD+ + H4folate
GCS
⇔ NH3 + CO2 +  NADH + H
+ + 5,10˗methylene˗H4folate  
There are four components of the GCS: three enzymes designated as proteins P, T, and 
L, and one structural carrier protein, called protein H. Protein P is a pyridoxal phosphate-
dependent protein or glycine dehydrogenase; protein T is amino-methyltransferase; 
protein L is known as dihydrolipoamide dehydrogenase; and protein H, the carrier protein, 
is a lipoic acid-containing protein (Kikuchi 1973; Kikuchi et al. 2008; Motokawa and 
Kikuchi 1969). Thus, a simple reaction for glycine deamination requires multiple enzymes 
for completion to ensure that errors leading to excess catabolism of glycine are minimized. 
The process of glycine degradation through the GCS complex consists of three reactions: 
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decarboxylation, amino-methyl transfer, and reoxidation of the reduced lipoate group 
(Figure 1.2). The glycine cleavage reaction is unlikely to be reversible under physiological 
conditions.    
A number of studies have investigated the regulation of GCS activity in animals. 
Hormones, metabolic status, proteins, fatty acids, and concentrations of ions in plasma 
affect GCS activity (Jois et al. 1992; Lowry et al. 1985b; Mudd et al. 2007; Wu et al. 
2014). Increasing the extracellular concentrations of glucagon or free Ca2+ enhances the 
activity of the glycine decarboxylase complex in mitochondria of the rodent liver (Jois et 
al. 1992). Metabolic acidosis also promotes the degradation of glycine via the GCS 
pathway in renal cortex tubule cells. The underlying mechanisms may include the 
accumulation of ammonia from glycine metabolism, which can aid in maintaining 
homeostasis of whole-body pH (Lowry et al. 1985b). Moreover, dietary protein intake 
activates glycine oxidation via GCS (Wang et al. 2013a).  
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Figure 1.2. The glycine cleavage system (GCS). Protein P: glycine dehydrogenase, red; protein H: lipoic 
acid binding protein, blue; protein T: amino-methyl transferase, yellow; protein L: FAD-requiring 
dihydrolipoamide dehydrogenase, green. 
 
Glycine catabolism through serine hydroxymethyl transferase 
For glycine catabolism, SHMT is at the convergence of two key pathways: glycine 
metabolism and nucleotide/protein biosynthesis (Amelio et al. 2014). As noted previously, 
SHMT catalyzes the reversible reactions for serine and glycine catabolism in the body. 
Glycine catabolism provides serine and one-carbon units from N5, N10-methylene-
tetrahydrofolate. The activity of SHMT is high in the ovary, placenta, fetal hepatocytes, 
and adult kidneys. This provides evidence for intracellular partitioning of serine and 
glycine metabolism from early to later in adult life, which is important for reproduction, 
fetal development, and survival (Lewis et al. 2005; Lowry et al. 1985b; Narkewicz et al. 
1996; Thureen et al. 1995).  
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Glycine is utilized in different metabolic pathways via inter-organ coordination. 
Results from rats and pigs show a nonlinear relationship between glycine supplementation 
and the concentration of serine in plasma (Lowry et al. 1985b; Shoham et al. 2001; Wang 
et al. 2013a). It is likely that formation of serine from glycine is highly compartmentalized 
within cells and that glycine derived from serine is not released into the blood. This 
possibility, however, seems to be remote because only a small amount of serine is 
generated from glycine in cultured muscle cells (Sun et al. 2015) and enterocytes (Wang 
et al. 2014). Alternatively, folate availability limits the conversion of glycine into serine 
(Wang et al. 2013).  
Quantitative analysis of endogenous glycine requirements for sow-reared pigs 
 The homeostasis of glycine is regulated by dietary intake, synthesis, and utilization of 
glycine. Some studies indicate that the amount of glycine from the diet and synthesis from 
serine, threonine, and choline is adequate for maximal weight gain (Sanborn et al. 1975; 
Schirch and Gross 1968).  
Quantitative analysis of glycine intake and synthesis 
The quantitative analysis of glycine intake and synthesis in sow-reared piglets is 
calculated based on results from previous studies (Wang et al. 2013). The amounts of 
glycine from milk and endogenous synthesis are summarized in Table 1.1. 
Although sow’s milk was traditionally thought to provide sufficient amino acids for 
supporting the optimal growth of neonatal piglets, sow-reared piglets grow at a suboptimal 
rate (Kim and Wu 2004; Wu 2010). Based on the quantitative analysis in Table 1.1, the 
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estimated intake of glycine from sow’s milk provides, at most, only 20 % of the glycine 
required by the 7-day-old pig (Table 1.1). Therefore, at least 80% of the glycine needed 
by the neonate must be provided through endogenous synthesis. 
For the last 50 years, serine has been considered as the main substrate for glycine 
synthesis in animals. However, serine conversion into glycine is limited. About 81% of 
serine in milk is utilized for protein synthesis and the diet provides at most 0.32 g of serine 
for glycine formation in young pigs (Wu 2010). The synthesis of glycine from choline and 
choline esters (glycerophosphocholine, phosphatidylcholine, and phosphocholine) 
provides about 36 mg/kg BW/day of glycine for sow-reared piglets (Donovan et al. 1997). 
Moreover, the amount of glycine synthesized from threonine is, at most, only 33 mg/kg 
BW/day in piglets. Thus, the amount of glycine from sow’s milk and endogenous 
synthesis is about 456 mg/kg BW/day or nursing piglets.  
Quantitative analysis of glycine requirements for growth and metabolic functions 
Glycine has critical physiological functions in nutrition, metabolism, reproduction, 
and disease. About 80% of dietary glycine is used for protein accretion, and glycine 
accounts for 11.5% of total amino acids in the proteins of animal bodies (Wang et al. 
2013a; Wu et al. 2013; Yan and Sun 1997). Therefore, young pigs have a particularly high 
requirement for glycine.  
The average daily gain of a 7-day-old piglet is 200 g/day, and includes 27.2 g protein, 
which means that at least 1.22 g glycine is required to meet requirements for body weight 
gain of piglets (Wang et al. 2013a). As noted previously, glycine is the main substrate for 
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the synthesis of creatine (Brosnan et al. 2009), purine (Hall 1998; Hellwing et al. 2007), 
bile acid, heme (Wang et al. 2013a), and hepatic glutathione (Reeds et al. 1997). Based on 
those reports, the amount of glycine required for those metabolic functions is 189 mg/kg 
BW/day, as detailed in Table 1.1. Moreover, 96 mg glycine/kg BW/day is oxidized into 
ammonia and CO2 in young pigs. Accordingly, the total amount of glycine required for 
protein accretion and metabolic functions is 1,204 mg/kg BW/day in sow-reared piglets.  
Thus, there is an imbalance between glycine supply and utilization. The piglet must 
be able to synthesize 1.05 g glycine/kg BW/day from precursors other than serine, 
threonine, and choline. At present, the alternative pathways for glycine synthesis are 
largely unknown in neonatal piglets.  
Hydroxyproline-glycine pathway in rodents and humans 
Of particular interest, there is a strong link between glycine synthesis and 
hydroxyproline metabolism in rodents and humans. Hydroxyproline can be converted to 
glycine in the rodent liver (Ribaya and Gershoff 1979; Takayama et al. 2003) and kidneys 
(Lowry et al. 1985a), human liver (Baker et al. 2004) and human body (Knight et al. 2006; 
Melendez-Hevia et al. 2009). Published results indicate that the liver and kidney of 
mammals are the main sites for glycine synthesis from hydroxyproline. The specific 
biochemical process of the hydroxyproline-glycine pathway was proposed based on 
research with human colon cells, fibroblasts, and peripheral leukocytes (Cooper et al. 2008; 
Valle et al. 1979). The most direct evidence for the hydroxyproline-glycine pathway was 
reported by Ruiz-Torres and Kürten (1976) who found that after labeled 4-hydroxy-L-
proline was administered to rats, 80% the labeled hydroxyproline was converted to glycine 
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within 1 hour. Those results suggested that free hydroxyproline was converted into glycine 
in animals (Ruiz-Torres and Kurten 1976). However, tissues other than liver and kidney 
that can synthesize glycine from hydroxyproline in any animal species is unknown. Based 
on previous studies, Wu (2013b) hypothesized that the hydroxyproline-glycine pathway 
exists in pigs (Figure 1.3) and that this pathway accounts for the majority of glycine 
synthesized in young pigs rather than synthesis of glycine from serine, threonine or choline 
(Wu 2013b).  
 
Table 1.1. Quantitative analysis of the glycine balance (glycine from milk and endogenous synthesis versus 
the metabolic demands of nursing piglets) of 7-day-old sow-reared piglets. Adapted and revised from Wang 
et al. (2013).  
 
 
 
Amount of glycine (mg/kg BW per day) 
Glycine from sow’s milk   
      Digestible milk intake (0.78 L/day; 1.2 g/L of whole milk) 311 
Glycine from endogenous synthesis  
      Glycine from dietary serine 81 
      Glycine from dietary threonine 31 
      Glycine from dietary choline 33 
The maintenance, metabolic and growth requirements for glycine 
      Body composition (protein & collagen) 
      Oxidation of “C” and “N” from glycine 
      Others metabolic molecules synthesis 
 (including creatine, purines, bile acids, glutathione, and heme) 
Unknown glycine synthesis sources 
 
1,216 
96 
 
189 
1045 
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The synthesis of glycine from hydroxyproline (Hyp) is an energy producing process. 
1 mole of FADH2 and NADH and 2 moles of pyruvate are produced during this process, 
which suggests that the conversion of hydroxyproline to glycine is preferred by animal 
bodies for glycine synthesis due to the production of both energy and glycine in this 
pathway. The first step in the pathway is oxidation of hydroxyproline, and that is the rate-
limiting step in the synthesis of glycine from Hyp. The key enzyme, hydroxyproline 
oxidase (OH-POX) oxidizes Hyp into Δ1-pyrroline-3-hydroxy-5-carboxylate (3-OH-
P5C). 3-OH-P5C is degraded by Δ1-pyrroline-5-carboxylate dehydrogenase and that same 
enzyme catalyzes the synthesis of Δ1-pyrroline-5-carboxylate (P5C) (Valle et al. 1979). 
Gamma-hydroxyglutamate is produced from 3-OH-P5C, and serves as a substrate for 
synthesis of glyoxylate by glutamate-oxaloacetate transaminase (GOT) and 4-hydroxy-2-
oxoglutarate aldolase (HOA) (Holmes and Assimos 1998). The final step in glycine 
synthesis is from glyoxylate by alanine: glyoxylate transaminase (AGT). 
There are reasons for this biochemical process being the major pathway for glycine 
synthesis in the neonatal pig. First, there are abundant amounts of Hyp in sow’s milk and 
tissues of piglets for synthesis of glycine. The glycine-proline-Hyp tripeptide (GPH) is the 
most abundant amino acid repeat (the basic structure unit) in collagen. There is a relatively 
high concentration of GPH in sow's milk. The concentration of Hyp (including peptide-
bound and free forms) is about 8.9 mM on day 7 of lactation, and 1.5 times higher during 
early lactation than during later stages of lactation (Wang et al. 2013b). Second, the yield 
of ATP from this pathway requiring 1 mole of FADH2 and NADH and 2 moles of 
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pyruvate leads to the production of about 29 mole ATP. Thus, the Hyp-Gly pathway is 
energetically efficient for glycine production in the body. 
 
 
Figure 1.3. The proposed hydroxyproline-glycine pathway in neonatal pigs. Ala, Alanine; AGT, 
alanine:glyoxylate transaminase; α-KG, α-ketoglutarate; Glu, Glutamate; GOT, glutamate:oxaloacetate 
transaminase; P5C, Δ1-pyrroline-5-hydroxy-5-carboxylate; OAA, oxaloacetate; Pyr, pyruvate. Adapted and 
revised from Wu (2013b). 
 
Physiological roles of glycine for growth 
The physiological functions of glycine in animal growth and maintenance were 
ignored for a long time. Glycine was traditionally classified as a “non-essential amino 
acid” for mammals only because the endogenous pathways for synthesis of glycine in vivo 
was thought to just meet metabolic requirements by animals. However, growing evidence 
indicates that glycine has positive effects on improving animal growth and feed efficiency 
for lean tissue gain. 
In animals fed a milk or plant-based diet, endogenous synthesis of glycine is 
insufficient to meet metabolic demands of the neonate (Wang et al. 2013a; Wu et al. 2014). 
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A large amount of glycine must be synthesized de novo to maintain homeostasis (Wang 
et al. 2013a). Because cell proliferation, protein synthesis, and nutrient utilization all 
depend on nucleic acid synthesis from glycine, glutamine, and folate, glycine is critical 
for animal growth, development, and health.  
Glycine supplementation stimulates growth in animals 
As a conditionally essential amino acid, glycine supplementation may be effective in 
improving nitrogen balance in animals. Results of recent studies indicate that endogenous 
synthesis of glycine does not meet metabolic requirements of sow-reared or post-weaning 
piglets, and that exogenous glycine increases daily weight gain and feed efficiency of 
growing pigs (Powell et al. 2011; Wang et al. 2014a; Wu et al. 2013). For example, Wang 
et al. (2014) reported that dietary supplementation with 2% glycine for 2 weeks increased 
average daily weight gain in milk-fed piglets, compared with the control piglets (Wang et 
al. 2014a). Powell et al. (2011) found that dietary supplementation with 0.52% glycine 
enhanced average daily weight gain and gain:feed intake ratio in 20-50 kg pigs fed a low-
protein diet (13% crude protein). These results indicate that the amount of glycine 
provided from endogenous synthesis plus the low-protein diet cannot support maximum 
growth performance in pigs (Powell et al. 2011). 
For avian species, glycine synthesis cannot meet metabolic demands since it is one of 
the amino acids used for synthesis of uric acid in the liver. Glycine supplementation to 
neonatal chickens may decrease muscle protein degradation and inhibit the expression of 
proteolytic-related genes, by suppressing concentrations of corticosterone in plasma 
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(Nakashima et al. 2008). Additionally, for growing chicks, at least 2.44% glycine plus 
serine is required in 16% crude protein diets (Dean et al. 2006). Corzo et al. (2004) 
suggested that dietary glycine should be at least 0.98% for 7- to 28-day-old broiler chicks 
to grow maximally (Corzo et al. 2004). 
The roles of glycine in protein accretion in skeletal muscle 
The accumulation and turnover of skeletal muscle are important for animal growth and 
meat production, since it is a large mass in the animal body which accounts for 40 ~ 45% 
of total body weight (Wu 2013b). Skeletal muscle has an anabolic response to glycine in 
various animal species, and the modulatory effects of glycine on muscle may result from 
the regulatory roles of glycine in activating the MTOR signaling pathway and one-carbon 
unit metabolism (Ham et al. 2016; Koopman et al. 2017; Ost et al. 2015; Sun et al. 2016a). 
Specifically, glycine supplementation promotes protein accretion (increasing protein 
synthesis and decreasing protein degradation) in the mouse myoblast cell line (C2C12). 
Expression of MTOR signaling pathway proteins, p-Akt, p-MTOR, p-P70S6K, and p-
4EBP1 were enhanced, and AMPK (an inhibitor of MTOR pathway) pathway was down-
regulated in response to supplemental dietary glycine. The rate of protein synthesis was 
increased, and the rate of protein degradation was decreased when the concentration of 
glycine increased from 0 to 1 mM (Sun et al. 2016a). With the improvement in protein 
synthesis, muscle mass will increase. Glycine can restore muscle mass under conditions 
of inflammation by: 1) inhibiting proteolysis and attenuating protein loss (Ham et al. 
2016); 2) maintaining Akt-MTOR-FOXO1 signaling; and 3) suppressing the activation of 
TLR4 and/or NOD2 signaling pathways (Liu et al. 2016).  
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The protective roles of glycine on the GI tract 
The gastrointestinal tract is the main site digestion and absorption of components of 
the diet in animals, and optimal health of the GI tract is a prerequisite for optimal growth 
and production in animals. Accumulating evidence indicates that there is a positive effect 
of glycine on gastrointestinal health and development. First, glycine is a cytoprotective 
factor for prevention of enterocyte damage in both in vitro and in vivo models. The 
protective effects of glycine on ischemia-reperfusion (IR) injury in the small intestine are 
well-documented in humans, pigs, and rodents (Wang et al. 2013). The underlying 
mechanisms may relate to up-regulation of glycine transporter (GLYT1), down-regulation 
of cell death signaling, such as Bax and caspase-3, in the intestinal mucosa (Jacob et al. 
2003). Second, glycine is highly effective in protecting the small intestine from 
inflammation and oxidative stress in humans and animals (Howard et al. 2010; Lee et al. 
2002; Li et al. 2016; Razak et al. 2017; Tsune et al. 2003; Wang et al. 2014b). The anti-
oxidative roles of glycine in the GI tract are achieved, in part, through glutathione 
synthesis. GSH is capable of scavenging reactive oxygen species (ROS), free radicals, 
peroxides, and lipid peroxides by either directly removing free radicals, or by reducing 
ROS. This physiological process is very efficient in enterocytes (Howard et al. 2010; 
Wang et al. 2014b; Wu 2013b). Additionally, glycine supplementation to 
lipopolysaccharide (LPS)-pretreated rats can increase their survival rate by decreasing 
tumor necrosis factor alpha (TNFA) and other pro-inflammatory cytokines in the small 
intestine (Ikejima et al. 1996). There is also evidence for the protective roles of glycine in 
tumor formation and growth in the intestine (Amin et al. 2003; Tsune et al. 2003). Third, 
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physiological concentrations of glycine help to maintain the intestinal mucosal barrier by 
modulating the expression and distribution of mucosal barrier proteins [(claudin-7 and 
tight junction 3 protein (ZO-3)] in intestinal epithelial cells (Li et al. 2016), because the 
intestinal mucosal barrier is critical for GI health, nutrient absorption, and utilization 
(Wang et al. 2015). 
Heme synthesis and one carbon metabolism 
The pathway of heme synthesis from glycine was discovered in the 1940s (Radin et 
al. 1950; Shemin et al. 1948). The heme-containing hemoprotein carries oxygen in red 
blood cells in blood of animals, and the heme-containing myoglobin stores oxygen in 
muscle for mitochondrial respiration and biogenesis (Wang et al. 2013a; Wu 2009). The 
family of hemoproteins includes hemoglobin, myoglobin, cytochromes, guanylate 
cyclase, NADH dehydrogenase, and coenzyme Q reductase (Poulos 2014). Cytochromes, 
NADH dehydrogenase, and coenzyme Q reductase play essential roles in energy supply 
and mitochondrial biogenesis (Dai et al. 2013; Wu et al. 2014). Another function of heme 
is to produce carbon monoxide (CO). CO, like nitric oxide (NO), is an endogenous cellular 
gas signaling molecule, and has important regulatory functions in vivo (Dai et al. 2013; 
Wang et al. 2013a). By triggering cGMP formation, CO induces protein phosphorylation 
reactions to regulate energy balance and smooth muscle relaxation (Wu 2013a). Moreover, 
CO can modulate immune system functions and neurotransmission (Wu and Wang 2005).  
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Figure 1.4. The roles of glycine in one carbon unit metabolism in cells. Betaine, choline, cysteine, 
glucose, homocysteine, serine, and tetrahydrofolate participate in the transfer of one-carbon units for 
multiple physiological functions in animals. Enzymes and co-factors involved are: (1) choline 
dehydrogenase; (2) betaine:homocysteine methyltransferase and vitamin B12; (3) dimethylglycine oxidase; 
(4) sarcosine oxidase; (5) serine hydroxymethyl transferase; (6) glycine cleavage system; (7) 
formyltransferase; (8) enzymes for DNA and RNA synthesis; (9) S-adenosylmethionine synthase; (10) S-
adenosylmethionine, a major methyl group donor in methyltransferase reactions,; (11) S-adenosyl-
homocysteine hydrolase; (12) cystathionine β-synthase and cystathionine γ-lyase; (13) γ-glutamyl-cysteine 
synthetase and glutathione synthetase; (14) a sequential series of enzymes that convert cysteine to pyruvate; 
(15) enzymes required for gluconeogenesis; and (16) a sequential series of enzymes that convert glucose to 
serine. Cys, cysteine; DMG, dimethylglycine; GSH, glutathione; Glu, glucose; Gly, glycine, Hcy, 
homocysteine; Met, methionine; meTHF, N5-N10-methylenetetrahydrofolate; ROS, reactive oxygen species; 
SAH, S-adenosylhomocysteine; SAM, S-adenosyl-methionine; Ser, serine; THF, tetrahydrofolate; Pyr, 
pyruvate. 
 
The understanding of physiological functions and regulation of cellular one-carbon 
unit metabolism is limited. The core role of one-carbon unit metabolism is transferring 
one-carbon units from specific amino acids to different target sites for multiple 
physiological functions. There are two main pathways for one-carbon unit metabolism 
(Figure 1.4): the folate-related pathway and the methionine-related pathway. The glycine 
synthesis and catabolism pathways are involved in one-carbon unit transfer, which is 
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important in nutrient metabolism, epigenetic regulation, mitochondrial biogenesis, cellular 
redox state balance, and oncogenesis (Ducker and Rabinowitz 2017; Locasale 2013). 
Recent genetic, functional, and clinical evidence indicates a link between cancer 
pathogenesis and glycine metabolism (Locasale 2013).  
Metabolism and functions of hydroxyproline/proline 
Different from other α-amino acids in chemical structure, proline (Pro) and 
hydroxyproline (Hyp) are unique as imino acids (Wu 2013b). Hydroxyproline, primarily 
4-hydroxy-L-proline, is found in acid hydrolysates of gelatin. Hydroxyproline is not a 
proteinogenic imino acid, but a product of the post-translational hydroxylation of proline 
(Hausmann and Neuman 1961). The structures of Pro and Hyp, and the conversion from 
Pro to Hyp are as follows.  
 
Proline residues in proteins (mainly collagen) can be hydroxylated to either 4- or 3-
hydroxy-L-proline residues in the endoplasmic reticulum of cells of most animals (Gorres 
and Raines 2010; Krane 2008). However, the production and amounts of 3-hydroxy-L-
proline are limited in vivo. The abundance of 4-hydroxy-L-proline residues is 
approximately 100 times greater than 3-hydroxy-L-proline residues in animal collagen 
(Krane 2008; Wu et al. 2011).  
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Physiological functions of Pro and Hyp 
Proline and hydroxyproline play versatile physiological roles in animal maintenance, 
growth, reproduction, tumorigenesis, and anti-oxidation, especially for young animals 
(Wu et al. 2017). First, Pro and Hyp are abundant in collagen. Pro and Hyp constitute 
approximately 30% of the amino acids in whole-body collagen (Wu et al. 2011). There 
are reports that dietary supplementation with Hyp or proline improves collagen synthesis 
and growth of animals, including pigs, chickens, and fish (Li and Wu 2017). However, the 
anti-oxidative and apoptosis-modulatory roles of Hyp have been demonstrated in recent 
years (Wu et al. 2017). Hyp can scavenge free radicals and produce reactive oxygen 
species (ROS) for regulation of cellular redox status (Cooper et al. 2008; Phang and Liu 
2012; Wu et al. 2011). The key enzyme for Hyp catabolism, hydroxyproline oxidase (OH-
POX), mediates the caspase-9 pathway, and induces apoptosis of cells (Cooper et al. 
2008). There is a suggestion that proline degradation could be an alternative energy source 
for ATP generation in cells with a limited supply of nutrients (Pandhare et al. 2009). 
Second, there is more and more evidence indicating that proline has vital regulatory roles 
in protein turnover by activating the MTOR signaling pathway in young animals. Wu et 
al. (2011) reported that dietary supplementation with 2% proline enhanced body weight 
gain in weanling piglets. Compared with the low-protein diet, supplementing 9% proline 
to an enteral diet had positive effects on protein accretion in the liver, muscle, small 
intestine, and skin of neonatal miniature piglets (Brunton et al. 2012). Third, by producing 
polyamines via proline oxidase, ornithine aminotransferase, and ornithine decarboxylase 
in placentae and the neonatal small intestine, proline supports their rapid growth through 
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stimulating protein synthesis and cell proliferation. These effects of proline provide a 
biochemical basis for using proline to reduce intrauterine growth restriction (IUGR) in 
mammals (Wu et al. 2008).  
Summary and objectives 
Glycine accounts for 11% of total amino acids in animal proteins, and can be 
synthesized in the liver from dietary serine, threonine, and choline. Thus, glycine was 
traditionally classified as a non-essential amino acid. However, there is increasing 
evidence that glycine has versatile roles to support growth and health, metabolic regulation 
and cytoprotection, as well as serve as an antioxidant and anti-inflammatory amino acid 
in animals. The nutritional significance of glycine in one-carbon unit metabolism can be 
extended to epigenetic regulation (DNA or protein methylation), mitochondrial 
biogenesis, and cellular redox signaling. The amount of endogenous glycine synthesized 
is not sufficient to meet metabolic needs of animals (including young pigs); therefore, 
dietary supplementation of glycine is required to optimize health and growth of piglets. 
The concentrations of glycine in plasma of IUGR piglets suggest that glycine is deficient 
in low-birth-weight piglets (<1.1 kilograms, IUGR). Based on these results, glycine should 
be categorized as a conditionally essential amino acid for animals.  
Glycine from milk meets only 23% of requirements for protein synthesis in neonatal 
piglets. Moreover, the contributions of serine, threonine, and choline to glycine synthesis 
from provide only 11% of the piglet’s total glycine requirement (Wang et al. 2013a; Wu 
and Knabe 1994; Wu et al. 1999). At least 0.71 g glycine/kg BW/day is needed for tissue 
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protein synthesis. There are reports that hydroxyproline is converted into glycine in the 
liver and kidney of rodents and in the human body. However, it is unknown whether other 
tissues possess the capacity for synthesizing glycine from hydroxyproline. Furthermore, 
nothing is known about this metabolic pathway in any tissues of farm animals, including 
pigs.  
The central hypothesis of this dissertation is that hydroxyproline is a major precursor 
for glycine synthesis in sow-reared pigs. Moreover, glycine deficiency contributes to the 
suboptimal growth and high mortality in IUGR piglets, and the glycine deficiency can be 
ameliorated by dietary supplementation with glycine. The overall objectives of this 
dissertation research were to: 1) identify novel endogenous pathways for the synthesis of 
glycine in neonatal pigs; 2) explain the basis for low concentrations of glycine in the 
plasma of IUGR pigs; and 3) define the nutritional role of glycine in neonatal pigs. 
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CHAPTER II  
GLYCINE SYNTHESIS FROM HYDROXYPROLINE IN  
TISSUES OF NEONATAL PIGS 
 
The present study was conducted to investigate glycine synthesis from 4-
hydroxyproline in tissues of sow-reared pigs. At 0, 7, 14 and 21 days of age, 6 piglets were 
sacrificed for each age group and their tissue samples were obtained for metabolic studies, 
as well as the determination of amino acids, activities of glycine-synthetic enzymes, 
protein localization, and gene expression. Our results indicated that at birth, 
hydroxyproline oxidase (OH-POX), proline oxidase (POX), alanine:glyoxylate 
transaminase (AGT), and 4-hydroxy-2-oxoglutarate aldolase (HOA) (key enzymes for 
glycine synthesis from hydroxyproline) were present in the liver and kidneys. Except for 
AGT, all of those enzymes were absent from skeletal muscle, heart, small intestine, and 
pancreas. At all ages, AGT was present in all the tissues, but the heart. The activities of 
the glycine-synthetic enzymes were decreased in the liver and kidneys between days 0 and 
day 21, but increased in the pancreas and small intestine over time (P < 0.05). Similar 
results were obtained for expression of mRNAs for those enzymes. For serine-glycine and 
threonine–glycine pathways: the enzymatic activities and expression of mRNAs for serine 
hydroxymethyl transferase (SHMT) and threonine dehydrogenase (TDH) increased from 
day 0 to day 21 of age in most tissues (P < 0.05). The localization of OH-POX and POX 
shifted from the periportal to perivenous hepatocytes in the liver as the piglets grew. With 
increasing age, the abundances of OH-POX and POX decreased in the liver, but increased 
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in the pancreas, small intestine, and stomach. Skeletal muscle and gallbladder expressed 
OH-POX and POX, but the abundances of those two proteins did not change with age. 
Tissues incubated with 0 to 5 mM hydroxyproline synthesized glycine in a concentration-
dependent manner, but the conversion of glycine into serine was limited. These novel 
findings indicate that hydroxyproline, an abundant metabolite in sow’s milk and a product 
of collagen degradation, is an important substrate for glycine synthesis in young pigs, 
instead of serine and threonine. 
Introduction 
Glycine is one of the most abundant amino acids in animals and comprises about 30% 
of the collagen and elastin in the body (Wu 2009; Wu et al. 2014; Wu et al. 1999). Glycine 
participates in the formation of N5-N10-methylenetetrahydrofolate from N5-
methyltetrahydrofolate and, thus, plays an important role in one-carbon unit metabolism 
(Jackson 1991; Mudd et al. 2007; Wang et al. 2013a). With the action of glycine N-
methyltransferase, glycine reacts with S-adenosyl methionine (SAM) to form sarcosine 
and S-adenosyl-homocysteine, thereby affecting the availability of SAM for DNA and 
protein methylation (Mudd et al. 2007). Glycine can be synthesized from serine (Shemin 
1946), threonine (Chao et al. 1953), and choline (Soloway and Stetten 1953) via well-
established pathways. Serine hydroxymethyltransferase (SHMT) catalyzes the reaction of 
serine to glycine, whereas threonine dehydrogenase (TDH) initiates the degradation of 
threonine to yield glycine. Furthermore, glycine is synthesized from choline via a series 
of reactions involving sarcosine formation.  
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Results of recent studies have shown that glycine from milk meets only 23% of the 
requirements of neonatal piglets for protein synthesis (Wu 2013c). Moreover, serine, 
threonine, and choline provide, at most, only 11% of the piglet’s total glycine requirement 
(Wang et al. 2013a; Wu and Knabe 1994; Wu et al. 1999). Clearly, additional substrates 
exist for glycine synthesis in piglets.  
There are reports that hydroxyproline can be converted to glycine in the liver (Ribaya 
and Gershoff 1979; Takayama et al. 2003) and kidney (Lowry et al. 1985a) of rodents, as 
well as liver (Baker et al. 2004) and body tissues of humans (Knight et al. 2006). The 
specific biochemical processes of the hydroxyproline-glycine pathway were also 
elucidated in these species (Cooper et al. 2008; Knight et al. 2006; Lowry et al. 1985a; 
Melendez-Hevia et al. 2009; Takayama et al. 2003; Valle et al. 1979). However, little is 
known about hydroxyproline metabolism in newborn pigs. Therefore, the present study 
was conducted to determine if hydroxyproline is the major substrate for glycine synthesis 
in tissues of sow-reared pigs. To achieve this goal, a series of experiments were performed 
to determine enzymatic activities, expression of mRNAs and proteins for key enzymes, 
cell-specific localization of proteins, and direct quantification of glycine production from 
4-hydroxyproline.  
Materials and methods 
Pigs  
The experimental protocol of this study was approved by the Texas A&M University 
Institutional Animal Care and Use Committee. 
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Piglets were the offspring of Yorkshire x Landrace sows and Duroc boars. They were 
maintained at the Texas A&M University Swine Center. The average litter size of sows 
was 12.4 at weaning. Throughout the gestation and lactation periods, sows had free access 
to water and corn-soybean meal based diets that met NRC requirements (NRC 2012). On 
days 0, 7, 14, and 21 of age, six piglets for each day of age with average body weights of 
1.41 ± 0.12, 3.13 ± 0.31, 4.03 ± 0.18, and 5.51 ± 0.34 kg were randomly selected and 
euthanized, as described previously (Hu et al. 2015).   
Collection of tissues collection from piglets 
At 0, 7, 14 and 21 days of age, after blood sampling, piglets were anesthetized with an 
intramuscular injection of Telazol (10 mg/kg body weight) and then euthanized by 
intracardiac administration of saturated KCl. After the abdomen was opened, the heart, 
liver, lung, stomach (with luminal contents being removed), pancreas, spleen, jejunum 
(proximal half of the remaining small intestine, with luminal contents being removed), 
kidneys, gallbladder, skeletal muscle, skin and brain were quickly isolated and weighted 
(Wang et al. 2014c). Tissues were cut into small portions, and some were fixed in freshly 
prepared 4% (wt/vol) paraformaldehyde in PBS (pH 7.2) for 24 h, followed by storage in 
70% ethanol for 24 h. The fixed tissues were dehydrated through a graded series of alcohol 
to xylene and embedded.  
Slices of fresh tissues were placed in ice-cold Krebs-Henseleit buffer (KHB) before 
being used in explant cultures (see below). The remaining portions of the tissues were 
frozen in liquid nitrogen and stored at -80°C.  
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Analysis of enzymatic activities of tissues 
Tissue homogenate. Frozen tissue (0.5 g) was homogenized in 2 mL of freshly 
prepared buffer consisting of 300 mmol/L sucrose, 5 mmol/L HEPES (pH 7.4), 1 mmol/L 
EDTA, 3 mmol/L dithiothreitol, 0.5% (v:v) Triton X-100, and 0.1% (wt:v) protease 
inhibitor (aprotinin, chymostatin, pepstatin A, and phenylmethylsulfonyl fluoride; 5 
µg/mL each) for 2 min on ice (Lowry et al. 1985). The whole homogenization mixture 
was transferred to a tube, which was centrifuged at 600 x g for 10 min at 4°C. The 
supernatant fluid was subjected to three cycles of freezing in liquid nitrogen and thawing 
in a 37°C water bath before use for enzyme assays (Carnie et al. 1982; Lowry et al. 1985a; 
Lowry et al. 1985b). 
Activity of hydroxyproline oxidase. The assay for hydroxyproline oxidase was 
performed as described by Carnie et al. (1982) with modifications Briefly, the assay 
solution (3 mL) consisted of 40 mM KPi (pH 8.0), 150 mmol/L hydroxyproline, 8 µmol/L 
cytochrome C (C2506; Sigma-Aldrich), and 0.3 mL of tissue homogenate. The solution 
was incubated at 37°C. After 0 and 30 min, 0.8 mL of the mixture was added to 1.6 mL 
of 40% ethanol and 6% trichloroacetic acid (TCA) which contained 1 mg/mL O-
aminobenzaldehyde (A9628; Sigma-Aldrich). The mixture was allowed to stand for 30 
min at room temperature, and centrifuged at 600 x g for 10 min to acquire the supernatant 
fluid for measurement of optical density (OD) at the wavelength of 443 nm. Buffer (80 
mmol/L KPi buffer, pH 8.0) was used instead of 600 mmol/L hydroxyproline in the blank 
tube (Carnie et al. 1982; Lowry et al. 1985a). The enzymatic activity was calculated 
according to the following formula: 
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Activity of proline oxidase. The activity of proline oxidase in different tissues was 
measured as described by Wu et al. (1997). Briefly, the reaction mixture contained 30 
mmol/L proline, 0.2 mmol/L cytochrome C, 50 mmol/L KPi buffer (pH 7.5), and tissue 
homogenate. The solution was incubated at 37°C for 30 min, and then 10% TCA was 
added to stop the reaction, followed by the addition of 0.1 mL of 100 mmol/L O-
aminobenzaldehyde. The mixture was allowed to stand for 30 min at room temperature 
and then centrifuged at 600 x g for 10 min. The supernatant fluid was used for 
measurement of OD at the wavelength of 440 nm. In the blank, 10% TCA was added to 
the assay mixture before incubation (Herzfeld et al. 1977). The enzymatic activity was 
calculated according to the following formula: 
 
Activity of 4-hydroxy-2-oxoglutarate aldolase. The activity of 4-hydroxy-2-
oxoglutarate aldolase in tissues was determined as previously described (Carnie et al. 
1982). Briefly, the reaction solution (2 ml) contained 0.2 mL of homogenate 100 mmol/L 
DL-4-hydroxy-2-ketoglutarate (disodium salt), and 100 mmol/L KPi buffer (pH 7.8). The 
mixture was incubated at 37°C for 20 min, and 10% TCA was added to stop the reaction. 
After the solution was centrifuged at 600 x g for 10 min, the supernatant fluid was used to 
measure pyruvate as previously described (Li et al. 2009). Buffer (100 mmol/L KPi buffer, 
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pH 7.8) was used instead of 100 mmol/L DL-4-hydroxy-2-ketoglutarate (disodium salt) 
in the blank group. 
Activity of alanine: glyoxylate transaminase. The activity of alanine:glyoxylate 
transaminase was determined by quantifying pyruvate production, as described by Rowell 
et al. (1972). Briefly, the assay solution (0.5 mL) contained 0.02 mL of tissue homogenate, 
100 mmol/L glyoxylic acid, 100 mmol/L alanine, and 100 mmol/L KPi buffer (pH 7.4). 
The mixture was incubated at 37°C for 20 min, and 10% TCA was added to stop the 
reaction. The solution was centrifuged at 600 x g for 10 min. The supernatant fluid was 
analyzed for pyruvate, as previously described (Rowsell et al. 1972). Buffer (100 mmol/L 
KPi buffer, pH 7.4) was used instead of 100 mmol/L glyoxylic acid in the blank tube. 
Activity of threonine dehydrogenase. Threonine dehydrogenase was analyzed by 
measuring NADH accumulation as described by Chen et al. (2009). Briefly, 0.02 mL of 
homogenate was added to a mixture of 100 mmol/L Tris/HCl (pH 8.4), 5 mmol/L NAD, 
0.125 mmol/L pyridoxal phosphate, and 50 mmol/L threonine. The solution was incubated 
at room temperature for 10 min, and OD values read at the wavelength of 340 nm using a 
microplate reader. Buffer (100 mmol/L Tris/HCl, pH 8.4) was used instead of 50 mmol/L 
threonine in the blank tube. 
Serine hydroxymethyltransferase. The assay solution consisted of 0.1 mL of tissue 
homogenate, 20 mmol/L L-serine, 0.36 mmol/L tetrahydrofolic acid, and 100 mmol/L KPi 
buffer (pH 7.5). The mixture was incubated at 37°C for 20 min. The reaction was 
terminated by addition of 0.2 mL of 1.5 mol/L HClO4, followed by addition of 0.1 mL of 
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2 mol/L K2CO3. After being centrifuged at 10,000 rpm for 2 min, the supernatant fluid 
was used for analysis of glycine using high performance liquid chromatography (HPLC) 
(Hu et al. 2015; Wu et al. 1997; Wu and Knabe 1994; Wu and Meininger 2008). 
Pyruvate determination. Pyruvate, a product of HOA and AGT, was determined using 
lactate dehydrogenase, as described by Wu et al. (1995). Briefly, 0.2 mL pyruvate standard 
or sample was mixed with 0.15 mL of 50 µM NADH and 1.5 mL 150 mM phosphate 
buffer (pH 7.5). After a 2 min incubation at room temperature, fluorescence was measured 
at the excitation wavelength of 340 nm and an emission wavelength of 460 nm in a 
Molecular Devices Spectra Max M2 microplate reader. Then, 5 µL of L-lactate 
dehydrogenase was added to the assay well. After a 5 min incubation at room temperature, 
fluorescence was measured again. The difference in fluorescence before and after the 
addition of lactate dehydrogenase was used to calculate concentrations of pyruvate on the 
basis of the pyruvate standard curve. 
RNA isolation and quantitative Real-Time PCR analyses 
Total RNA was isolated from piglet tissues using Trizol (15596026; Invitrogen) 
according to Jobgen et al. (2009). The quantity and quality of the total RNA were 
determined by spectrometry (wavelength 230 nm). The expression of mRNAs for 
hydroxyproline oxidase (PRODH2) (Summitt et al. 2015), 4-hydroxy-2-oxoglutarate 
aldolase (HOGA), alanine-glyoxylate aminotransferase (AGXT2), proline oxidase 
(PRODH1), serine hydroxymethyltransferase (SHMT2), and L-threonine dehydrogenase 
(TDH) in different tissues were determined by quantitative real-time polymerase chain 
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reaction. Primers were designed using the Primer Express Software Version 1.5 (Applied 
Biosystems). Primer pairs for selected genes are summarized in Table 2.1. The 
quantitative PCR was performed using the ABI prism 7900HT system (Applied 
Biosystems) with the Power SYBR Green PCR Master Mix (4309155; Applied 
Biosystems) as instructed by the manufacturer. Swine 18S ribosomal (RN18S, GenBank 
No. NR_046261) was used as the reference gene (Table 2.1). The abundance of mRNAs 
was calculated using the comparative Ct method (Wang et al. 2014d). 
Immunohistochemical analyses 
Immunohistochemical localization of OH-POX and POX proteins in piglet tissues was 
performed as described previously (Wang et al. 2014d) in tissue sections (∼5 μm) with 
rabbit anti-OH-POX immunoglobulin G (IgG) (Adapted from Dr. James M. Phang, NIH), 
and rabbit anti-POX polyclonal IgG (HPA020361; Sigma-Aldrich) at a dilution of 1:500 
and 1:200, respectively. Antigen retrieval was performed by boiling the sample in 0.01 M 
sodium citrate buffer, pH 6.0. Purified nonrelevant rabbit or mouse IgG was used as a 
negative control to replace the primary antibody at the same final concentration. 
Immunoreactive protein was visualized in sections using the VECTASTAIN ABC Kit 
(PK-6101 for rabbit IgG; Vector Laboratories) and 3,3′-diaminobenzidine 
tetrahydrochloride (D5637; Sigma-Aldrich) as the color substrate. 
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Table 2.1. Primer pairs sequence for selected genes 
 
Production of glycine by tissues incubated with hydroxyproline 
The production of glycine in tissues incubated with 4-hydroxyproline was determined 
using an established method (Self et al. 2004; Wu et al. 1989). Slices of (~100 mg) freshly 
isolated tissues from piglets were incubated at 37oC for 2 h in 2 mL oxygenated KHB 
buffer containing 5 mM D-glucose, 20 mM HEPES (pH 7.4), and 0, 0.1, 0.25, 0.5, 2, or 5 
mM 4-hydroxyproline. The reaction was terminated by addition of 200 µL of 1.5 mol/L 
HClO4. The tissue plus the incubation medium was homogenized for 2 min on ice, and the 
solution was neutralized with 100 µL of 2 mol/L K2CO3. After being centrifuged at 600 x 
g for 5 min at 4 °C, the supernatant fluid was used for HPLC analysis of amino acids (Wu 
and Meininger 2008). In parallel experiments, concentrations of amino acids before 
incubation were also determined as previously described. 
Gene  Accession 
number 
Forward primer sequence (5' - 3') Reverse primer sequence (5' - 3') 
18S NR_046261 CTTGCAGGGCGGTGACAG GCCCTCGGTCGAGTTGTC 
AGT XM_013997641 GATCTACACGCGGAAGACC GCTGTACAAGCCAATGACG 
GOT 2 NM_213928 TATGTCACCGTGCAGACCAT AGGAAGACATCTCGGCTGA 
HOGA NM_001190169 TGCACTCGTTTGGGAAACCT AAGGGCTAGAATGCAGCTC 
POX NM_011172 GAGGACCAGGAGTCCATC CAGGACTCCATCTCCTTG 
PRODH 2 NM_021232 GTGACCATGTCTCCTTGGCA CCGCAGTACACTTCGGTTC 
SHMT 2 NM_021232 GAGAGTCTATCAGACAGTG CGAGTACTTGTTGTTCAGA 
TDH NM_214004 CCAGAGCCGTGAACATCAC AGAAGTGGGTCCAAAAGCC 
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Statistical analysis        
Results are expressed as means ± SEM. Statistical analyses of data were performed by 
one-way analysis of variance using the General Linear Models procedures (Assaad et al. 
2014). Differences among treatment means were determined using the Student-Newman-
Keuls (SNK) multiple comparison method (Assaad et al. 2014). A probability value of ≤ 
0.05 was taken to indicate statistical significance.  
Results 
Enzymatics activities of the hydroxyproline-glycine pathway  
Figures 2.1 to 2.2 illustrate the enzymatic activities of OH-POX, POX, HOA, and AGT 
in tissues from piglets. OH-POX catabolizes the conversion of hydroxyproline into ∆1-
pyrroline-3-hydroxy-5-carboxylate (3-OH-P5C), which is a rate-controlling enzyme for 
the hydroxyproline-glycine pathway (Lowry et al. 1985a; Phang et al. 1981; Ruiz-Torres 
and Kurten 1976; Takayama et al. 2003; Valle et al. 1979; Wu et al. 2011). The activities 
of OH-POX in the liver and kidney decreased gradually during the first 3 weeks of 
postnatal life. OH-POX activity was not detected in the heart (day 0 to day 14), skeletal 
muscle (days 0 and 7), small intestine (day 0), or stomach (days 0-21). OH-POX activity 
in the pancreas and small intestine tended to increase between days 7 and 21 of age.  
For comparison, the activity of POX, which oxidizes proline to ∆1-pyrroline-5-
carboxylate (P5C), was not detected in the heart (days 0 to 14), skeletal muscle (day 0), 
pancreas (day 0), or stomach (days 0 to 14). However, the liver and kidney had high POX 
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activity at birth, which decreased progressively as the piglet became older (P < 0.05). POX 
activity in the small intestine increased progressively with age.  
 
 
 
 
 
 
Figure 2.1. The enzymatic activity for hydroxyproline oxidase (OH-POX) in tissues from piglets at 
different ages (days 0, 7, 14 and 21). The results indicated that liver and kidney have the greatest 
hydroxyproline oxidase enzymatic activity as newborn piglets. Values are expressed as means ± SEM, n = 
6 per time point. a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by 
one-way ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
Figures 2.3 to 2.4 illustrate the enzymatic activities of HOA and AGT play roles in the 
metabolism of various amino acids to produce pyruvate, which is then oxidized via the 
Krebs cycle for energy (ATP) (Wang et al. 2014c). As shown in Figure 2.3, HOA activity 
was great from days 7 to 21 of age in the pancreas (no enzymatic activity on day 0), but 
enzymatic activity decreased moderately in the kidney with increasing age of the piglets. 
The activity of AGT increased in the liver during the first 3 weeks of life, decreased in the 
 
Hydroxyproline oxidase (OH-POX) (µmole/min/g tissue) 
Day 0 Day 7 Day 14 Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
----- 
6.48 ± 0.43a 
----- 
8.89 ± 0.21a 
1.89 ± 0.04a 
----- 
----- 
3.35 ± 0.18b 
----- 
8.30 ± 0.07b 
3.93 ± 0.21b 
1.99 ± 0.14a 
----- 
2.15 ± 0.12c 
1.77 ± 0.20 
5.53 ± 0.17c 
8.98 ± 0.22c 
2.28 ± 0.47a 
1.41 ± 0.13 
1.52 ± 0.18d 
2.21 ± 0.08 
5.95 ± 0.14c 
15.3 ± 1.20d 
6.29 ± 0.39b 
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kidney, and increased markedly by three-fold in both the pancreas and small intestine by 
postnatal day 21.  
 
 
Figure 2.2. The enzymatic activity of proline oxidase (POX) in tissues from piglets at different days of 
age (days 0, 7, 14 and 21). The results indicated that the liver and kidney had the greatest proline oxidase 
activity at birth. Values are expressed as means ± SEM, n = 6 per time point. a-b means in a row without a 
common superscript letter differ (P < 0.05) as analyzed by one-way ANOVA, and intergroup comparisons 
were made by Student–Newman–Keuls (SNK).  
 
 
Proline oxidase (POX) (µmole/min/g tissue) 
Day 0 Day 7 Day 14 Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Stomach 
----- 
5.27 ± 0.28a 
----- 
4.88 ± 0.15a 
----- 
1.01 ± 0.09a 
----- 
----- 
3.12 ± 0.11b 
0.86 ± 0.07a 
2.55 ± 0.10b 
2.22 ± 0.16a 
2.16 ± 0.06b 
----- 
----- 
3.04 ± 0.15b 
1.05 ± 0.05b 
2.89 ± 0.13b 
5.70 ± 0.24b 
3.50 ± 0.26c 
----- 
0.75 ± 0.09 
2.13 ± 0.12c 
1.22 ± 0.03c 
2.10 ± 0.07c 
7.13 ± 0.15c 
5.99 ± 0.18d 
0.68 ± 0.04 
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Figure 2.3. The enzymatic activity for 4-hydroxy-2-oxoglutarate aldolase (HOA) in tissues from piglets 
on different ages (days 0, 7, 14 and 21). Values are expressed as means ± SEM, n = 6 per time point. a-b 
means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way ANOVA and 
the Student–Newman–Keuls (SNK) multiple comparison test. 
 
 
 
 
4-hydroxy-2-oxoglutarate aldolase (HOA) (µmole/min/g tissue) 
Day 0 Day 7 Day 14 Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Stomach 
----- 
1.10 ± 0.10a 
----- 
1.37 ± 0.13a 
----- 
----- 
----- 
----- 
0.65 ± 0.09b 
----- 
1.81 ± 0.16ab 
1.79 ± 0.13 
0.55 ± 0.05a 
----- 
----- 
0.81 ± 0.05b 
0.06 ± 0.01 
1.97 ± 0.13b 
1.76 ± 0.15 
0.51 ± 0.02a 
----- 
----- 
0.34 ± 0.05c 
0.08 ± 0.02 
2.06 ± 0.18b 
2.06 ± 0.14 
0.72 ± 0.05b 
0.39 ± 0.04 
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Figure 2.4. The enzymatic activity for alanine:glyoxylate transaminase (AGT) in tissues from piglets 
on different days of age (days 0, 7, 14 and 21). Values are expressed as means ± SEM, n = 6 per time point.  
a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way ANOVA 
and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
Enzymatic activities of serine-glycine and threonine–glycine pathways  
For comparing the capacity of the hydroxyproline-glycine pathway to synthesize 
glycine with that of the serine-glycine and threonine-glycine pathways, the activities of 
SHMT and TDH in tissues were determined. The liver and pancreas had the highest 
enzymatic activities among tissues between days 0 and 21 of age. The activity of SHMT 
in those two organs was lower at birth than at day 21 (Figure 2.5). Other organs had lower 
SHMT activity than the liver and kidneys.  TDH activity was not detected in the heart, 
skeletal muscle, stomach, and small intestine of piglets at any age studied. As shown in 
 
 
Alanine:glyoxlate transaminase (AGT) (µmole/min/g tissue) 
Day 0 Day 7 Day 14 Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Stomach 
----- 
1.25 ± 0.09a 
0.12 ± 0.02 
2.14 ± 0.10a 
1.07 ± 0.15a 
0.48 ± 0.06a 
0.07 ± 0.02 
----- 
1.35 ± 0.10a 
0.18 ± 0.02 
3.10 ± 0.13b 
2.73 ± 0.20b 
0.91 ± 0.07b 
0.06 ± 0.01 
----- 
1.84 ± 0.07b 
0.18 ± 0.03 
3.95 ± 0.10c   
2.75 ± 0.11b 
1.25 ± 0.11c 
0.09 ± 0.02 
----- 
1.89 ± 0.12b 
0.14 ± 0.01 
4.85 ± 0.12d 
3.37 ± 0.12c 
1.28 ± 0.05c 
0.10 ± 0.02 
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Figure 2.6, TDH activity in the pancreas, liver, and kidneys increased as the piglets grew 
(P < 0.05). 
 
 
 
 
 
Figure 2.5. The enzymatic activity for serine hydroxymethyltransferase (SHMT) in tissues from piglets 
on different days of age (days 0, 7, 14 and 21). Those results indicated that liver and pancreas are the main 
sites for serine-glycine conversion after day 14 of age. Values are expressed as means ± SEM, n = 6 per 
time point. a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-
way ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
 
Serine hydroxymethyltransferase (SHMT) (µmole/min/g tissue) 
Day 0 Day 7 Day 14 Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Stomach 
----- 
1.02 ± 0.09 
----- 
3.26 ± 0.24a 
----- 
----- 
----- 
----- 
1.13 ± 0.19 
----- 
5.34 ± 0.06b 
2.39 ± 0.27a 
0.44 ± 0.05 
----- 
----- 
1.08 ± 0.18 
0.67 ± 0.03 
6.89 ± 0.28c 
4.75 ± 0.32b 
0.35 ± 0.08 
----- 
----- 
1.29 ± 0.07 
0.71 ± 0.09 
8.38 ± 0.37d 
6.31 ± 0.26c 
0.36 ± 0.03 
1.29 ± 0.26 
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Figure 2.6. The enzymatic activity of threonine dehydrogenase (TDH) in tissues from piglets on 
different days of age (days 0, 7, 14 and 21). Those results indicated that the conversion of threonine into 
glycine is limited in most tissues, and that liver and pancreas are the main sites for threonine-glycine 
conversion after day 14 age. Values are expressed as means ± SEM, n = 6 per time point. a-b means in a 
row without a common superscript letter differ (P < 0.05) as analyzed by one-way ANOVA and the Student–
Newman–Keuls (SNK) multiple comparison test. 
 
Expression of mRNA for enzyme proteins in tissues from piglets on different days of life    
Quantitative real-time PCR was used for the analysis of genes encoding enzymes of 
the hydroxyproline-glycine pathway. Compared with results from the enzyme assays, 
expression of mRNAs for hydroxyproline oxidase (PRODH2) and proline oxidase 
(PRODH1) showed the same changes in the liver and kidneys, namely, high expression at 
birth that decreased with age. As shown in Figure 2.7 and 2.8, the expression of mRNAs 
for those two genes in the liver and kidneys were 5.6 and 5.8 times higher, respectively, 
 
 
Threonine dehydrogenase (TDH) (µmole/min/g tissue) 
Day 1 Day 7 Day 14 Day 21 
Kidney 
Liver 
Pancreas 
0.03 ± 0.03a 
0.77 ± 0.13a 
2.68 ± 0.27a 
0.09 ± 0.04ab 
1.62 ± 0.33b 
6.73 ± 0.11b 
0.16 ± 0.02bc 
1.59 ± 0.12b 
6.37 ± 0.53b 
0.19 ± 0.01c 
2.74 ± 0.03c 
9.24 ± 0.82c 
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on day 0 than on day 21 (P < 0.05). At day 21 of age, the pancreas had the greatest 
expression of mRNAs for PRODH1 and PRODH2 among all of the tissues examined. 
 
Figure 2.7. The expression of mRNA for hydroxyproline oxidase (gene name as PRODH2) in tissues 
from piglets on different days of age (days 0, 7, 14 and 21). Those results have the same tendency as OH-
POX enzymatic activity with respect to age and growth. Values are expressed as means ± SEM, n = 6 per 
time point. a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-
way ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
 
 
 
 
 mRNA expression for PRODH2 
   Day 0    Day 7    Day 14    Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Stomach 
1.00 ± 0.12a 
1.00 ± 0.05a 
1.00 ± 0.13a 
1.00 ± 0.08a 
1.00 ± 0.12a 
1.00 ± 0.15a 
1.00 ± 0.17a 
2.03 ± 0.09b 
0.63 ± 0.09b 
1.01 ± 0.03a 
0.51 ± 0.06b 
2.21 ± 0.13b 
1.71 ± 0.23a 
1.79 ± 0.18b 
3.19 ± 0.29c 
0.40 ± 0.04c 
1.59 ± 0.14b 
0.47 ± 0.05b 
5.41 ± 0.47c 
5.56 ± 0.59b 
1.48 ± 0.14ab 
3.58 ± 0.58c 
0.18 ± 0.03d 
1.68 ± 0.21b 
0.27 ± 0.01c 
6.84 ± 0.41c 
5.82 ± 0.49b 
1.63 ± 0.16b 
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Figure 2.8. The expression of proline oxidase (gene name as PRODH1) mRNA in tissues from piglets 
on different days of age (days 0, 7, 14 and 21). Those results have the same tendency as POX enzymatic 
activity with respect to age and growth. Values are expressed as means ± SEM, n = 6 per time point.  a-b 
means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way ANOVA and 
the Student–Newman–Keuls (SNK) multiple comparison test. 
 
As the downstream enzymes in the hydroxyproline-glycine pathway, HOA and AGT 
convert the product of OH-POX into glycine (Valle et al. 1979; Wang et al. 2013a). 
Expression of mRNAs for those two genes increased with age in the pancreas and small 
intestine, but decreased in the liver (Figures 2.9 and 2.10). There were no appreciable 
changes in HOA and AGT in the liver or kidneys.  
 mRNA expression for PRODH 
Day 0 Day 7   Day 14    Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Stomach 
1.00 ± 0.11a 
1.00 ± 0.05a 
1.00 ± 0.07a 
1.00 ± 0.05a 
1.00 ± 0.12a 
1.00 ± 0.17a 
1.00 ± 0.06a 
1.07 ± 0.07a 
0.80 ± 0.04b 
1.17 ± 0.13a 
0.76 ± 0.06b 
2.15 ± 0.13b 
1.37 ± 0.20ab 
2.01 ± 0.05b 
3.04 ± 0.17b 
0.45 ± 0.02c 
1.96 ± 0.16b 
0.32 ± 0.03c 
7.48 ± 0.18c 
1.75 ± 0.13bc 
3.14 ± 0.20c 
4.67 ± 0.20c 
0.28 ± 0.02d 
2.98 ± 0.15c 
0.19 ± 0.01d 
8.47 ± 0.29c 
2.19 ± 0.09c 
3.09 ± 0.18c 
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Figure 2.9. The expression of mRNA for 4-hydroxy-2-oxoglutarate aldolase (gene name as HOGA) in 
tissues from piglets on different days of age (days 0, 7, 14 and 21). Values are means ± SEM, n = 6 per time 
point. a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way 
ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
 
 
 mRNA expression for HOGA 
Day 0 Day 7    Day 14    Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Stomach 
1.00 ± 0.08 
1.00 ± 0.05ab 
1.00 ± 0.12 
1.00 ± 0.19a 
1.00 ± 0.18ab 
1.00 ± 0.14a 
1.00 ± 0.19a 
0.96 ± 0.08 
1.18 ± 0.19a 
1.04 ± 0.12 
0.74 ± 0.08ab 
1.05 ± 0.10b 
1.94 ± 0.16b 
1.23 ± 0.11a 
1.19 ± 0.21 
0.71 ± 0.07b 
1.15 ± 0.20 
0.65 ± 0.03ab 
1.84 ± 0.27c 
3.56 ± 0.24c 
1.85 ± 0.12b 
1.39 ± 0.22 
0.34 ± 0.02c 
1.38 ± 0.11 
0.49 ± 0.02b 
1.69 ± 0.20ac 
4.01 ± 0.25c 
1.73 ± 0.16b 
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Figure 2.10. The expression of mRNA for alanine-glyoxylate transaminase (gene name as AGXT2) in 
tissues from piglets on different days of age (days 0, 7, 14 and 21). Values are expressed as means ± SEM, 
n = 6 per time point. a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed 
by one-way ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
The changes in expression of mRNAs for SHMT and TDH followed similar patterns 
to those for their enzymatic activities. In the liver and pancreas (Figures 2.11 and 2.12), 
the two genes had very limited expression at birth, but expression of their mRNAs 
increased with age (P < 0.05).  
 
 
 mRNA expression for AGXT2 
Day 0 Day 7    Day 14    Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Stomach 
1.00 ± 0.09 
1.00 ± 0.09 
1.00 ± 0.22 
1.00 ± 0.07 
1.00 ± 0.14a 
1.00 ± 0.07a 
1.00 ± 0.13a 
1.31 ± 0.18 
0.97 ± 0.10 
1.19 ± 0.16 
0.99 ± 0.13 
2.22 ± 0.14b 
2.01 ± 0.21b 
1.41 ± 0.05a 
1.23 ± 0.12 
0.85 ± 0.12 
1.46 ± 0.16 
1.02 ± 0.10 
2.88 ± 0.16c 
2.43 ± 0.17b 
2.62 ± 0.19b 
1.45 ± 0.19 
0.88 ± 0.06 
1.76 ± 0.21 
1.01 ± 0.09 
3.78 ± 0.11d 
3.51 ± 0.20c 
2.49 ± 0.22b 
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Figure 2.11. Expression of mRNA for serine hydroxymethyltransferase (gene name as SHMT2) in 
tissues from piglets on different days of age (days 0, 7, 14 and 21). Values are expressed as means ± SEM, 
n = 6 per time point. a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed 
by one-way ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
 
 
 
 
 mRNA expression for SHMT2 
Day 0 Day 7    Day 14    Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver53 
Pancreas 
Small Intestine 
Stomach 
1.00 ± 0.08 
1.00 ± 0.15a 
1.00 ± 0.15 
1.00 ± 0.17a 
1.00 ± 0.04a 
1.00 ± 0.12a 
1.00 ± 0.11a 
1.09 ± 0.07 
1.31 ± 0.06ab 
1.16 ± 0.10 
2.50 ± 0.14b 
3.18 ± 0.12b 
2.99 ± 0.27b 
1.60 ± 0.18b 
1.20 ± 0.17 
1.55 ± 0.09b 
1.17 ± 0.10 
4.37 ± 0.31c 
5.92 ± 0.29c 
3.58 ± 0.09b 
1.67 ± 0.08b 
1.35 ± 0.12 
1.57 ± 0.18b 
1.25 ± 0.26 
5.59 ± 0.35d 
6.15 ± 0.19c 
4.63 ± 0.27c 
2.18 ± 0.16c 
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Figure 2.12. Expression of mRNA for threonine dehydrogenase (gene name as TDH) in tissue from 
piglets on different days of age (days 0, 7, 14 and 21). Values are expressed as means ± SEM, n = 6 per time 
point. a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way 
ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
Localization of OH-POX and POX proteins in pig tissues 
In order to investigate the spatial and temporal expression of the OH-POX and POX 
proteins, we conducted immunohistochemical analyses of tissues. In the liver of piglets 
there were spatial changes in for both OH-POX and POX proteins with age (Figures 2.13 
and 2.14). On day 0, OH-POX and POX proteins were specifically expressed in the 
periportal part of the classical liver lobule. On days 7 and 14, both proteins were present 
in the transitional part of the liver, and after postnatal day 21, the proteins were localized 
in the perivenous zone around the central vein in the liver.  
  
 mRNA expression for TDH 
Day 0 Day 7    Day 14    Day 21 
Kidney 
Liver 
Pancreas 
1.00 ± 0.17 
1.00 ± 0.08a 
1.00 ± 0.06a 
1.10 ± 0.15 
1.73 ± 0.11b 
1.27 ± 0.16a 
1.25 ± 0.05 
1.87 ± 0.16b 
2.15 ± 0.04b 
1.49 ± 0.09 
2.46 ± 0.07c 
2.51 ± 0.09c 
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Figure 2.13. The localization and quantification, using optical density (OD), of hydroxyproline oxidase 
protein in the liver of piglets at different ages (day 0, 7, 14, and 21). 
 
 
Figure 2.14. The localization and quantification, using optical density (OD), of proline oxidase protein 
in the liver of piglets at different ages (day 0, 7, 14, and 21). 
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The renal proximal tubule was the main site for OH-POX expression, and there was 
very limited expression in the distal tubules and glomeruli (Figure 2.15). In contrast, POX 
was expressed mainly in the distal tubules and glomeruli, but limited in the proximal 
tubule (Figure 2.16). Both OH-POX and POX proteins were highly expressed at birth and 
decreased to day 21, as observed for their enzymatic activities and mRNA transcripts. 
 
Figure 2.15. The localization of hydroxyproline oxidase protein in the kidney of piglets on postnatal 
days 0, 7, 14, and 21.  
 
Figure 2.16. The localization of proline oxidase protein in the kidney of piglets on postnatal days 0, 7, 
14, and 21. 
 52 
 
As shown in Figures 2.17 and 2.18, the expression of OH-POX was low in the pancreas 
at day 0, but increased after 14 days of age. Expression of POX protein in the pancreas 
was not detected by IHC staining on postnatal day 0.  
 
 
Figure 2.17. The protein of hydroxyproline oxidase protein in the pancreas on postnatal days 0, 7, 14, 
and 21. 
 
 
Figure 2.18. The localization of proline oxidase expression in the pancreas of piglets on postnatal days 
7, 14, and 21. 
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For the small intestine (jejunum), the OH-POX and POX proteins were expressed in 
enterocytes and intestinal glands (crypts) (Figures 2.19 and 2.20). Epithelial cells and 
glands are the major sites for both nutrient absorption and protein secretion in the small 
intestine. The same results were found for the stomach (Figures 2.21), with epithelial cells 
and glands as the main sites for POX expression. The expression of OH-POX protein in 
the small intestine was not detected by IHC staining. Moreover, OH-POX protein was not 
detectable in the stomach, and POX protein was not detected in the stomach of piglets 
until postnatal day 21.  
 
 
Figure 2.19. The localization of hydroxyproline oxidase protein in the small intestine of piglets on 
postnatal days 1, 7, 14, and 21. 
 54 
 
 
Figure 2.20. The localization of proline oxidase protein in the small intestine of piglets on postnatal 
days 1, 7, 14, and 21. 
 
 
Figure 2.21. The localization of proline oxidase protein in the stomach of piglets on postnatal day 21.  
 
Cardiac and skeletal muscles expressed OH-POX and POX at 21 days of age. IHC 
analyses detected both enzymes in the muscles between days 0 and 14 of life (Figures 2.22 
and 2.23). Figure 2.23 clearly shows the difference between the cardiac muscle, skeletal 
muscle and smooth muscle (arterial vascular muscle). There was no staining for OH-POX 
and POX in smooth muscle, but a low level of staining was found in cardiac and skeletal 
muscles. 
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Figure 2.22. The localization of hydroxyproline oxidase protein in cardiac and skeletal muscle from 
piglets on postnatal day 21. 
 
As shown for the liver (Figures 2.24 and 2.25), the bile duct in the liver of 21-day-old 
pigs expressed OH-POX and POX protein. These two proteins were also detected in the 
livers of piglets between postnatal days 0 and 14. Interestingly, both proteins were also 
present in epithelial cells of the gallbladder (Figures 2.24 and 2.25). 
 
 
Figure 2.23. The localization of proline oxidase protein in cardiac and skeletal muscles on postnatal day 
21.  
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Figure 2.24. The localization of hydroxyproline oxidase protein in both the bile duct, liver and 
gallbladder of piglets on postnatal day 21.  
 
 
Figure 2.25. The localization of proline oxidase protein in both bile duct and liver (postnatal day 1) and 
gallbladder on postnatal day 21. 
 
Glycine synthesis from tissues  
As shown in Tables 2.2 to 2.5, concentrations of glycine in the liver and kidney, as 
well as culture medium, increased in a dose-dependent manner as concentrations of 4-
hydroxyproline increased from 0 to 5 mM. This was also true for most of other tissues. 
Thus, the liver and kidney had a high ability to metabolize hydroxyproline into glycine in 
the first 2 to 3 weeks of postnatal life. However, the small intestine was a major organ for 
glycine synthesis from hydroxyproline in growing piglets. Muscle could convert 
hydroxyproline into glycine to some extent, but the heart, stomach, and gallbladder could 
not do so. 
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Table 2.2. Concentrations of glycine in incubation medium plus tissues from piglets on postnatal day 0 (nmol/mg tissue/2 h) * 
  
Concentrations of 4-Hydroxyproline in incubation medium of various tissues from neontal piglets 
Background 0 mM  0.1 mM 0.2 mM    0.5 mM  2 mM 5 mM 
Liver 1.36 ± 0.18a 1.59 ± 0.15a 3.32 ± 0.12b 5.55 ± 0.47c  9.97 ± 0.58d 12.1 ± 0.57e 16.3 ± 0.78f 
Pancreas 1.61 ± 0.20a 3.68 ± 0.40b 3.67 ± 0.57b 3.15 ± 0.55b 3.07 ± 0.13b 3.03 ± 0.17b 3.27 ± 0.21b 
Kidney 1.64 ± 0.10a 2.05 ± 0.29a 3.77 ± 0.04bc 5.42 ± 0.15c 9.09 ± 0.81d 11.9 ± 0.83e 14.2 ± 1.06f 
Small intestine 1.24 ± 0.03a 2.10 ± 0.28b 2.17 ± 0.35b 2.15 ± 0.18b 2.21 ± 0.28b 2.15 ± 0.16b 2.27 ± 0.29b 
 Skeletal muscle 1.40 ± 0.05 1.82 ± 0.16 1.98 ± 0.17 1.48 ± 0.02 1.88 ± 0.17  1.89 ± 0.14 1.90 ± 0.12 
* Values are as means ± SEM, n = 6 per time point.  a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way 
ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
Table 2.3. Concentrations of glycine in incubation medium plus tissues from 7-day-old pigs (nmol/mg tissue/2 h) * 
  
Concentrations of 4-Hydroxyproline in incubation medium for tissues 
Background 0 mM  0.1 mM 0.2 mM    0.5 mM  2 mM 5 mM 
Liver 2.14 ± 0.11a 2.45 ± 0.19a 3.89 ± 0.44a 6.13 ± 0.77b 8.07 ± 0.58b 12.9 ± 0.68c 14.3 ± 1.83c 
Pancreas 2.36 ± 0.09a 2.99 ± 0.04a 4.34 ± 0.71ab 4.74 ± 0.10bc 6.17 ± 0.16c 8.30 ± 0.24d 8.82 ± 0.18d 
Kidney 2.64 ± 0.07a 3.16 ± 0.38a 3.97 ± 0.36a 5.74 ± 0.69b 8.09 ± 0.98c 9.99 ± 0.72d 12.4 ± 0.65e 
Small intestine 2.71 ± 0.16a 4.66 ± 0.50ab 4.88 ± 0.73ab 5.96 ± 0.35b 6.66 ± 1.11b 7.20 ± 1.00b 7.17 ± 0.75b 
Skeletal muscle 1.85 ± 0.12 1.98 ± 0.23 2.10 ± 0.12 2.16 ± 0.21 2.18 ± 0.29 2.15 ± 0.21 2.18 ± 0.04 
* Values are means ± SEM, n = 6 per time point.  a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way 
ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
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 Table 2.4. Concentrations of glycine in incubation medium plus tissues from 14-day-old pigs (nmol/mg tissue/2 h) * 
  
Concentrations of 4-Hydroxyproline in incubation medium  
Background 0 mM  0.1 mM 0.2 mM    0.5 mM  2 mM 5 mM 
Liver 1.53 ± 0.16a 3.30 ± 0.52b 4.47 ± 0.06bc 5.44 ± 0.33c 7.30 ± 0.78d 11.2 ± 0.16e 13.3 ± 1.15f 
Pancreas 1.93 ± 0.03a 3.45 ± 0.88a 7.00 ± 0.61b 9.65 ± 1.18c 13.5 ± 0.72d 16.6 ± 1.14e 16.2 ± 0.67e 
Kidney 2.74 ± 0.28a 3.02 ± 0.57a 4.02 ± 0.08a 4.92 ± 0.91ab 6.15 ± 0.37b 8.62 ± 1.03c 8.40 ± 0.20c 
Small intestine 2.96 ± 0.04a 4.45 ± 0.14a 5.48 ± 0.10a 8.33 ± 0.25b 12.4 ± 1.89c 14.8 ± 0.30d 15.7 ± 0.94d 
Skeletal muscle 1.11 ± 0.09a 2.25 ± 0.64ab 4.29 ± 1.03bc 6.38 ± 1.49cd 7.56 ± 1.19d  10.8 ± 0.36e 10.2 ± 0.12e 
* Values are as means ± SEM, n = 6 per time point.  a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way 
ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
 
Table 2.5. Concentrations of glycine in incubation medium plus tissues from 21-day-old pigs (nmol/mg tissue/2 h) * 
  
Concentrations of 4-Hydroxyproline in incubation medium 
Background 0 mM  0.1 mM 0.2 mM    0.5 mM  2 mM 5 mM 
Liver 1.78 ± 0.28a 3.15 ± 0.60ab 4.61 ± 0.66b 5.50 ± 0.11bc 7.61 ± 0.54c 10.9 ± 1.43d 11.8 ± 1.16d 
Pancreas 0.98 ± 0.10a 2.77 ± 0.51a 5.72 ± 0.36b 9.03 ± 0.93c 12.7 ± 0.99d 13. 3 ± 1.14d 16.1 ± 0.19e 
Kidney 2.15 ± 0.04a 3.36 ± 0.29a 4.95 ± 0.22b 5.78 ± 0.83b 6.52 ± 0.57bc 8.02 ± 0.80cd 8.00 ± 0.09d 
Small intestine 1.67 ± 0.23a 3.54 ± 0.02ab 5.59 ± 0.17bc 7.96 ± 1.05c 12.1 ± 1.81d 15.4 ± 1.28e 17.7 ± 0.94e 
Skeletal muscle 2.00 ± 0.07a 3.37 ± 0.14ab 4.58 ± 0.42bc 5.90 ± 0.07c 8.18 ± 0.40d  9.59 ± 0.87e 9.88 ± 0.69e 
* Values are as means ± SEM, n = 6 per time point.  a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way 
ANOVA and the Student–Newman–Keuls (SNK) multiple comparison test. 
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Discussion 
Glycine, proline, and hydroxyproline are major constituents of extracellular matrix 
proteins, collagen and elastin (Wang et al. 2013a). The degradation of those proteins 
releases glycine-proline-hydroxyproline tripeptides into physiological fluids, such as 
blood and milk (Wu 2013a; Wu et al. 2011). Thus, this tripeptide is abundant in sow’s 
milk (up to 10 mM) and plasma of piglets (up to 3 mM) (Wu et al. 2017). For comparison, 
glutamine, which is the most abundant amino acid in sow’s milk, is present at 4 mM 
(Haynes et al. 2009), and glycine, which is the most abundant amino acid in plasma of 
piglets, is present at about 1 mM (Flynn et al. 2000). The unusual abundance of the Gly-
Pro-Hyp tripeptide in milk and blood raised an important question about its nutritional and 
physiological significance.  
The enzymatic activities of OH-POX, POX, HOA, AGT, SHMT, and TDH, which are 
involved in glycine synthesis, are summarized in Table 2.6. Hydroxyproline oxidase and 
POX play key roles in degrading hydroxyproline and proline, respectively.  OH-POX and 
POX are highly expressed in the liver and kidneys of newborn pigs (Figures 2.1 & 2.2) 
and provide a biochemical basis for the utilization of hydroxyproline and proline by those 
tissues. Consistent with this observation is a previous report that after 14C-labeled 
hydroxyproline and proline were administered into newborn pigs, the labeled amino acids 
rapidly appeared in their liver and kidneys to a much greater extent than in other organs 
(Bengtsson and Hakkarainen 1977). Thus, the liver and kidneys actively take up 
hydroxyproline and metabolize it to glycine in a concentration-dependent manner. This 
helps to explain high concentrations of glycine in plasma of piglets (Flynn et al. 2000). 
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Sufficient concentrations of glycine are needed to activate synthesis of muscle proteins 
and nucleotides (purines) (Sun et al. 2015).  
The hydrolysis of the Gly-Pro-Hyp tripeptide releases hydroxyproline that is 
subsequently catabolized to glycine and yield 4 mol ATP/mol substrate (Li et al. 2017). 
Nutritional stress (e.g. glucose deficiency) increases POX expression, which increases 
proline degradation for production of energy (ATP) (Pandhare et al. 2009). Similar 
nutritional stress occurs in newborn pigs. Thus, the catabolism of hydroxyproline via OH-
POX generates not only glycine, but also ATP to meet demands for the high metabolic 
rate of neonatal pigs.  
 
Table 2.6. Comparison of enzymatic activities related to glycine synthesis  
 
  Age of pigs 
Tissues Day 0 Day 7 Day 14 Day 21 
 Enzymatic activity of hydroxyproline oxidase  
Heart No No No + 
Kidney +++ ++ ++ + 
Skeletal Muscle No No ++ ++ 
Liver ++++ +++ +++ ++ 
Pancreas No + +++ ++++ 
Small Intestine No No ++ +++ 
Stomach No No No No 
 Enzymatic activity of proline oxidase  
Heart No No No + 
Kidney +++ +++ +++ + 
Skeletal Muscle No No + + 
Liver +++ ++ ++ ++ 
Pancreas No ++ +++ ++++ 
Small Intestine + ++ ++ +++ 
Stomach No No No No 
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Table 2.6. Continued 
 
  Age of pigs 
Tissues Day 0 Day 7 Day 14 Day 21 
 Enzymatic activity of 4-hydroxy-2-oxoglutarate aldolase  
Heart No + + + 
Kidney ++ ++ ++ + 
Skeletal Muscle No No No No 
Liver ++ ++ ++ ++ 
Pancreas No + ++ ++ 
Small Intestine No + + ++ 
Stomach No No No No 
 Enzymatic activity of alanine:glyoxylate transaminase  
Heart No No No No 
Kidney ++ ++ ++ ++ 
Skeletal Muscle + + + + 
Liver ++ ++ +++ +++ 
Pancreas + ++ ++ +++ 
Small Intestine + + ++ ++ 
Stomach + + + + 
 Enzymatic activity of serine hydroxymethyltransferase  
Heart No No No No 
Kidney ++ ++ ++ ++ 
Skeletal Muscle No No + + 
Liver +++ +++ ++++ ++++ 
Pancreas No ++ ++ +++ 
Small Intestine No + + + 
Stomach No No No + 
 Enzymatic activity of threonine dehydrogenase  
Heart No No No No 
Kidney + + ++ ++ 
Skeletal Muscle No No No No 
Liver + ++ ++ +++ 
Pancreas + ++ ++ ++++ 
Small Intestine No No No No 
Stomach No No No No 
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The liver of piglets exhibits cell-specific expression of both OH-POX and POX. There 
are two different types of hepatocytes (periportal and perivenous) and three distinct zones 
in the liver (Figure 2.26). The periportal and perivenous hepatocytes have very different 
metabolic patterns (Gebhardt 1992; Haussinger et al. 1992; Jungermann 1986). The 
hepatic zonation includes periportal (zone I), transitional (zone II), and perivenous (zone 
III) zones. A change in hepatic protein localization of both OH-POX and POX may 
indicate a shift in their function between birth and weaning. The periportal hepatocyte 
contains abundant mitochondria and participates in amino acid synthesis and catabolism 
(Haussinger 1983; Haussinger et al. 1992; Jungermann 1986). However, the perivenous 
hepatocyte contains fewer mitochondria and they are involved in fatty acid metabolism 
(Jungermann 1986; Le Hir and Dubach 1980). The high abundance of OH-POX and POX 
proteins in the periportal hepatocytes at birth may indicate that those cells have a greater 
capacity to catabolize hydroxyproline and proline to generate glycine than the perivenous 
hepatocytes. As neonatal piglets grow, the small intestine expressed higher levels of OH-
POX and POX (Figures 2.1 and 2.2) and becomes an active organ to degrading 
hydroxyproline and proline in milk to glycine and P5C, respectively. Thus, lesser amounts 
of these two dietary amino acids would enter the liver via the portal vein in 14- to 21-day-
old pigs than in 0- to 7-day-old pigs. Those hydroxyproline and proline that enter the liver 
would largely bypass the periportal hepatocytes and be degraded to glycine in the 
perivenous hepatocytes where glycine oxidation is limited. This spatial expression of 
glycine-metabolic pathways is physiologically important to maximize the synthesis of 
glycine in the liver.   
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Figure 2.26. A schematic diagram of the liver with a classic lobule, zonation, and vessels. Pink area, 
periportal zone (zone I); yellow area, transitional zone (zone II): and green area, perivenous zone (zone III). 
Nutrients are supplied from the portal vein to periportal hepatocytes, and exit the liver through the central 
vein. 
 
Any dietary hydroxyproline that escapes the liver and the hydroxyproline produced 
from the degradation of collagen and elastin in the connective tissue are taken up by the 
kidneys, skeletal muscle and possibly other tissues for glycine synthesis. In the kidneys, 
the proximal tubules of the cortex are the main site of OH-POX expression, 
hydroxyproline degradation, and glycine synthesis (Figure 2.15). Of interest, the proximal 
tubules of the kidney express argininosuccinate synthase and lyase for synthesis of 
arginine from citrulline, as well as arginine:glycine amidinotransferase that converts 
arginine and glycine into guanidinoacetate, the immediate precursor of creatine (Brosnan 
and Brosnan 2016). The colocalization of the enzymes for guanidinoacetate production in 
the same renal site can increase the efficiency of creatine synthesis. Likewise, the presence 
of glycine synthesis in skeletal muscle, which lacks enzymes for glycine degradation, can 
maximize the production of glycine locally to improve health and growth of piglets.     
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In conclusion, hydroxyproline is a major precursor for glycine synthesis in sow-reared 
pigs. OH-POX and POX, key enzymes for the degradation of hydroxyproline and proline 
as well as glycine synthesis, are highly expressed in the liver and kidneys of neonatal pigs. 
The pancreas, small intestine, and skeletal muscle of 14- to 21-day-old pigs synthesize 
glycine from hydroxyproline. The spatial and temporal changes in expression of glycine-
synthetic enzymes maximize the net production of glycine to compensate for a severe 
deficiency of glycine in sow’s milk, thereby supporting growth and development of 
piglets.   
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CHAPTER III  
IMPAIRED ENDOGENOUS SYNTHESIS OF GLYCINE FROM 
HYDROXYPROLINE IN INTRA-UTERINE GROWTH  
RESTRICTED (IUGR) PIGLETS 
 
Intrauterine growth restriction (IUGR) is one of the major problems in pig production, 
and there is a close association between IUGR and metabolic syndrome in later life. 
Previous evidence showed that the concentration of glycine in plasma of IUGR piglets is 
much lower than that in normal birth weight piglets. The present study was conducted to 
test the hypothesis that impairment of endogenous glycine synthesis contributes to glycine 
deficiency in IUGR piglets. At 0, 7, 14, and 21 days of age, six IUGR piglets and 6 normal 
birth-weight piglets were sacrificed, and samples of their tissues obtained for metabolic 
studies, as well as the determination of enzymatic activities, cellular localization and 
expression of mRNAs for glycine-synthetic enzymes. Our results indicated that: the 
enzymatic activities of hydroxyproline oxidase (OH-POX) and serine hydroxymethyl 
transferase (SHMT) were less in tissues of IUGR (P < 0.05) compared with normal piglets. 
The enzymatic activity of threonine dehydrogenase (TDH) did not differ between IUGR 
and normal piglets. Similar results were obtained for expression of mRNAs for those 
enzymes. Based on the results of immunohistochemistry (IHC), the abundance OH-POX 
protein was relatively low in the liver, small intestine, and skeletal muscle of IUGR piglets. 
These results indicate that endogenous synthesis of glycine is insufficient for maximal 
growth of sow-reared piglets.  
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Introduction 
Glycine has critical physiological functions in nutrition, metabolism, and health. 
Beyond serving as a building block of protein (including collagen), glycine is required for 
the synthesis of heme, purines, creatine, glutathione, and bile salts (Amelio et al. 2014; 
Hall 1998; Jois et al. 1992; Li et al. 2016; Matilla et al. 2002; Mudd et al. 2007; Petrat et 
al. 2012). In addition, glycine participates in one-carbon unit metabolism, which is 
required for DNA synthesis and cell growth (Razak et al. 2017). Furthermore, glycine is 
an anti-oxidative and anti-inflammatory amino acid that modulates protein, glucose and 
lipid metabolism in cells and tissues (Amelio et al. 2014; Hall 1998; Jois et al. 1992; Li et 
al. 2016; Matilla et al. 2002; Mudd et al. 2007; Petrat et al. 2012; Razak et al. 2017; Sun 
et al. 2016a; Wang et al. 2014a; Wang et al. 2013a; Wang et al. 2014b; Weinberg et al. 
2016; Wu et al. 2014). The amount of glycine in humans and animals is considerable. 
About 80% of dietary glycine is used for protein accretion, as glycine accounts for 11.5% 
of total amino acids in proteins of the whole body (Wang et al. 2013a; Wu et al. 2013; 
Yan and Sun 1997). Thus, a deficiency of glycine leads to growth restriction and oxidative 
stress in young pigs with a normal birth weight (Wang et al. 2014).  
Intrauterine growth restriction (IUGR) is defined as impaired growth of a mammalian 
embryo/fetus or its organs, which may result from limited uterine capacity, insufficient 
nutrient supply or maternal endocrine disturbances during gestation (Wu et al. 2006). 
There is a higher occurrence of IUGR in polytocous than monotocous mammals, due to 
the limitations of the functional capacity of the placenta, uteroplacental transfer of 
nutrients and oxygen transport from mother to fetus (Bazer et al. 1969; Wang et al. 2017). 
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The IUGR animals are below either the 10th percentile or the population mean minus two 
standard deviations. Based on the large numbers of observations of birth weights of 
newborn piglets, a birth weight less than 1.1 kilograms meets the criterion of IUGR in 
modern breeds of piglets (Marsal 2002; Wu et al. 2004; Wu et al. 2006).  
IUGR remains a major problem in the global swine industry. The pre-weaning survival 
rates decrease from 95 to 15% as piglet birth weights decrease from 1.80 to 0.61 kg (Wu 
et al. 2006). There is a close association between IUGR and onset of metabolic syndrome 
in later life (Wu et al. 2004). The concentration of glycine in the plasma of neonatal IUGR 
pigs is only about 50% of that in normal birth-weight piglets (Sun et al. 2015). IUGR 
offspring have increased risk for abnormal growth and development, hormonal 
imbalances, metabolic disorders, and inflammatory diseases (Barker and Clark 1997; Leon 
et al. 1998; Marsal 2002; Wu et al. 2004; Wu et al. 2006). This study tested the hypothesis 
that impaired synthesis of glycine from hydroxyproline contributed to a glycine deficiency 
in IUGR piglets. As reported in Chapter II, six IUGR piglets and six normal birth-weight 
piglets were sacrificed on postnatal days 0, 7, 14, and 21 and tissue samples were obtained 
for metabolic studies, as well as the determination of enzymatic activities, cell-specific 
localization and expression of mRNAs for glycine-synthetic enzymes.  
Materials and methods 
Pigs 
The experimental protocol for this study was approved by the Texas A&M University 
Institutional Animal Care and Use Committee.  
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Piglets were offspring of Yorkshire x Landrace sows and Duroc x Hampshire boars 
maintained at the Texas A&M University Swine Center. Sows were nursing an average of 
12 piglets at weaning. Throughout the lactation period, sows had free access to water and 
a corn-soybean meal based diet that met NRC requirements. Six IUGR and six normal 
birthweight piglets were selected randomly and sacrificed on postnatal days 0, 7, 14 or 21 
when average body weights were 0.78 ± 0.18, 1.50 ± 0.45, 2.23 ± 0.70, and 3.44 ± 0.63 
kg, respectively.    
Collection of blood samples and analysis of amino acids. 
On postnatal days 0, 7, 14 and 21, IUGR piglets were removed from sows for 1.5 h 
and jugular vein blood samples were withdrawn from each piglet into EDTA-containing 
tubes. The blood samples were centrifuged immediately at 10,000 rpm for 1 min, and 
plasma was stored at −80 °C until analyzed. Amino acids in plasma were analyzed by 
HPLC methods described previously (Hu et al. 2015; Wu et al. 1997; Wu and Knabe 1994; 
Wu and Meininger 2008). 
Collection of tissues from IUGR piglets. 
On postnatal days 0, 7, 14 and 21, after blood sampling, piglets were anesthetized with 
intramuscular injection of Telazol (10 mg/kg body weight) and then euthanized by 
intracardiac administration of saturated KCl. After the abdomen was opened, heart, liver, 
lung, stomach (with luminal contents removed), pancreas, spleen, jejunum (proximal half 
of the remaining small intestine, with luminal contents removed), kidney, gallbladder, 
skeletal muscle, skin, and brain were quickly isolated and weighted (Wang et al. 2014c). 
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Tissues were cut into small pieces, and a portion of the tissues was snap-frozen in liquid 
nitrogen and stored at −80°C while another portion of tissues was fixed in freshly prepared 
4% (wt/vol) paraformaldehyde in PBS (pH 7.2) for 24 h and then transferred to 70% 
ethanol for 24 h. The fixed tissues were dehydrated through a graded series of alcohol to 
xylene (Wu et al. 1996) and embedded in Paraplast-Plus (Oxford Labware).  
Analysis of enzymatic activities in tissues. 
The homogenization of tissues and the determination of enzymatic activities were 
performed as described in Chapter II.  
RNA isolation and quantitative Real-Time PCR analyses 
Total RNA was isolated from tissues of piglets using Trizol (15596026; Invitrogen) 
according to Jobgen et al. (2009) (Jobgen et al. 2009), and the analysis of gene expression 
was performed using quantitative real-time RT-PCR, as described in Chapter II. 
Immunohistochemical analyses 
Immunohistochemical localization of OH-POX proteins in piglet tissues was 
performed as described in Chapter II.  
Statistical analysis        
Results are expressed as means ± SEM. Statistical analyses of data were performed by 
one-way analysis of variance using the General Linear Models procedures (Assaad et al. 
2014). Differences among treatment means were determined using the Student-Newman-
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Keuls (SNK) multiple comparison method (Assaad et al. 2014). A probability value of ≤ 
0.05 was taken to indicate statistical significance.   
Results 
Enzymatic activity of hydroxyproline oxidase 
As discussed in Chapter II, hydroxyproline is the main substrate for glycine synthesis 
in neonatal piglets, and hydroxyproline oxidase (OH-POX) is the key and rate-controlling 
enzyme in the glycine-synthetic pathway (Lowry et al. 1985a; Phang et al. 1981; Ruiz-
Torres and Kurten 1976; Takayama et al. 2003; Valle et al. 1979; Wu et al. 2011). Based 
on results of the previous studies (Chapter II), the heart, liver, stomach (with luminal 
contents being removed), pancreas, jejunum (proximal half of the remaining small 
intestine, with luminal contents being removed), kidneys, and skeletal muscle from IUGR 
piglets and piglets with normal birth weights on postnatal days 0, 7, 14 and 21 were 
analyzed. 
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Figure 3.1. Enzymatic activity of hydroxyproline oxidase (OH-POX) in tissues from IUGR piglets on 
postnatal days 0, 7, 14 and 21. Values are expressed as means ± SEM, n = 6 per time point. Means in a row 
without a common superscript letter differ (P < 0.05) as analyzed by one-way ANOVA and the Student–
Newman–Keuls (SNK) multiple comparison test. 
 
Figure 3.1 shows the enzymatic activities of OH-POX in different tissues from piglets 
on postnatal days 0, 7, 14, and 21. OH-POX activity was not detected in cardiac muscle 
and stomach of piglets at any of the ages studied or skeletal muscle from 0- and 14-day-
old IUGR pigs. Surprisingly, the enzymatic activity was low in the liver, kidneys, and 
pancreas of IUGR piglets on days 0 and 7 of age. Of note, OH-POX activity was not 
detected in the small intestine of IUGR piglets. The capacity of hydroxyproline utilization 
in different tissues of both normal and IUGR piglets are summarized in Figures 3.2 and 
3.3. Specifically, IUGR piglets had only 6.8, 13.4, 6.6, and 68.8% of the capacity for 
 
Hydroxyproline oxidase (OH-POX) (µmole/min/g tissue) 
Day 0 Day 7 Day 14 Day 21 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
2.61 ± 0.09a 
----- 
0.93 ± 0.05a 
----- 
------ 
2.52 ± 0.11a 
----- 
1.16 ± 0.18a 
1.33 ± 0.12a 
0.86 ± 0.05a 
3.17 ± 0.17b 
----- 
3.29 ± 0.21b 
4.01 ± 0.15b 
1.77 ± 0.09b 
3.02 ± 0.14b 
0.74 ± 0.10 
4.53 ± 0.16b 
7.81 ± 0.49c 
4.06 ± 0.20c 
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hydroxyproline utilization as that for normal birth-weight piglets on postnatal days 0, 7, 
14, and 21, respectively. The contribution from the liver, small intestine, and skeletal 
muscle to glycine synthesis was limited in IUGR pigs.  
 
 
 
 
 
 
 
Figure 3.2. Estimation of the capacity of different tissues from piglets of normal body weights to utilize 
hydroxyproline on postnatal days 0, 7, 14 and 21. Liver (high enzyme ability) and skeletal muscle (large 
mass, accounting for 40% body weight in neonatal piglets) were the main sites for hydroxyproline 
catabolism on days 0 and 7. The small intestine became an important site for glycine synthesis on days 14 
and 21. 
  
 HYP utilization capacity in normal piglets (µmole/min) 
Day 0 Day 7       Day 14       Day 21 
Heart 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Sum 
0 
156 
0 
287 
2.95 
0 
446 
0 
69.0 
0 
765 
5.99 
198 
1038 
0 
55.7 
1485 
658 
12.3 
421 
2632 
45 
47.3 
2651 
997 
11.5 
1260 
5012 
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Figure 3.3. Estimation of the capacity of different tissues from IUGR piglets to utilize hydroxyproline 
on postnatal days 0,7,14 and 21. The utilization of hydroxyproline by IUGR piglets was low at birth 
compared with that for normal birth weight piglets, but increased with age. 
 
Serine hydroxymethyl transferase activity 
Serine is another source for glycine synthesis in neonatal pigs. The activities of serine 
hydroxymethyl transferase (SHMT) in tissues from different ages of IUGR piglets are 
shown in Figure 3.4. The SHMT activity increased in the liver, small intestine, and skeletal 
muscle from day 0 to day 21 of age. However, the enzymatic activity in the liver of IUGR 
piglets was very low compared with normal birth weight pigs. SHMT activities in the 
livers of IUGR piglets were only 27.8%, 56.0%, 58.5%, and 79.1% of those for normal 
 HYP utilization capacity in IUGR piglets (µmole/min) 
Day 0 Day 7       Day 14       Day 21 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
Sum 
14.4 
0 
17.2 
0 
0 
 31.6 
30.5 
0 
60.9 
2.66 
45.5 
 140 
48.6 
0 
224 
16.1 
151.2 
440 
75.5 
2394 
435 
35.5 
512 
3452 
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pigs on postnatal days 0, 7, 14, and 21, respectively. Because the liver is the main tissue 
for glycine synthesis via SHMT, this pathway was limited in neonatal IUGR piglets, 
especially in the first 2 weeks of life. The contributions of serine to glycine synthesis in 
different tissues of both normal and IUGR piglets are summarized as Figures 3.5 and 3.6.  
Of note, IUGR piglets had only 16.3, 30.6, 40.0, and 65.9% of the serine-glycine 
conversion capacities as normal piglets at 0, 7, 14, and 21 days of age, respectively. 
 
 
 
Figure 3.4. Enzymatic activity of serine hydroxymethyl transferase (SHMT) in tissues from IUGR 
piglets at different ages. Values are means ± SEM, n = 6 per time point. Means in a row without a common 
superscript letter differ (P < 0.05) as analyzed by one-way ANOVA and the Student–Newman–Keuls (SNK) 
multiple comparison test.  
 
 
 
Serine hydroxymethyl transferase (SHMT) (µmole/min/g tissue) 
        Day 0 Day 7 Day 14 Day 21 
Kidney 
Skeletal Muscle 
Liver 
Pancreas 
Small Intestine 
0.90 ± 0.03a 
----- 
1.46 ± 0.18a 
----- 
----- 
1.21 ± 0.14b 
----- 
2.99 ± 0.20b 
2.25 ± 0.14b 
----- 
1.29 ± 0.11b 
0.49 ± 0.02 
4.03 ± 0.19c 
4.14 ± 0.27c 
0.47 ± 0.08b 
1.27 ± 0.05b 
0.58 ± 0.06 
6.63 ± 0.22d 
4.82 ± 0.06d 
0.45 ± 0.06b 
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Figure 3.5. Estimation of the capacity for serine-glycine conversion in different tissues and at different 
ages for normal body weight piglets.  
 
 
 
 
 
 
 Ser-Gly conversion capacity in normal piglets (µmole/min) 
Day 0 Day 7       Day 14       Day 21 
Kidney 
Liver 
Pancreas 
Small Intestine 
Sum 
15.8 
177 
2.73 
28.9 
224 
23.2 
492 
13.0 
43.4 
572 
28.0 
819 
25.6 
50.0 
923 
40.3 
1106 
42.6 
66.6 
1255 
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Figure 3.6. Estimation of the capacities for serine-glycine conversion in different tissues of 0- to 21-
day-old IUGR piglets.  
 
Enzymatic activity of threonine dehydrogenase 
The contribution of threonine to endogenous glycine synthesis was limited in neonatal 
piglets, as shown in Figure 3.7. TDH activities in the liver, kidney, and pancreas of IUGR 
piglets were much lower than those in normal piglets. In contrast to normal neonates, TDH 
expression in the kidney and pancreas was not detected in IUGR piglets at birth. The 
 Ser-Gly conversion capacity in IUGR piglets (µmole/min) 
Day 0 Day 7       Day 14       Day 21 
Kidney 
Liver 
Pancreas 
Small Intestine 
Stomach 
Sum 
4.95 
26.3 
1.59 
9.28 
0 
42.1 
13.9 
157 
4.50 
12.6 
9.78 
198 
19.4 
274 
16.6 
39.9 
27.0 
377 
31.8 
636 
21.7 
56.7 
44.7 
791 
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activities in the liver and pancreas of IUGR piglets were, at most, only half of the values 
for normal birth weight piglets. 
 
 
Figure 3.7. Enzymatic activity of threonine dehydrogenase (TDH) in tissues of IUGR piglets at different 
ages. Values are means ± SEM, n = 6 per time point. Means in a row without a common superscript letter 
differ (P < 0.05) as analyzed by one-way ANOVA and the Student–Newman–Keuls (SNK) multiple 
comparison test. 
 
Expression of mRNAs for PRODH2, SHMT2, and TDH  
Expression of mRNAs for PRODH2, SHMT2, and TDH are summarized in Table 3.1. 
The expression of PRODH2 (OH-POX) mRNA in the liver of IUGR pigs was low at birth, 
and increased with growth and age. At 21 days of age, no difference in hepatic expression 
of OH-POX was detected between IUGR and normal pigs. Similar results were obtained 
for kidneys and skeletal muscle. However, the expression of mRNA for PRODH2 
 
 
Threonine dehydrogenase (TDH) (µmole/min/g tissue) 
Day 0 Day 7 Day 14 Day 21 
Kidney 
Liver 
Pancreas 
        ------- 
   0.53 ± 0.04a 
        ------- 
       ------- 
0.98 ± 0.03b 
2.12 ± 0.09a 
0.07 ± 0.02 
1.43 ± 0.10c 
4.06 ± 0.18b 
0.15 ± 0.03 
1.85 ± 0.09d 
5.34 ± 0.20c 
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remained lower in the small intestine and pancreas of 21-day-old IUGR piglets, compared 
with age-matched normal piglets (P < 0.05). 
The liver is the main site for SHMT2 expression (Amelio et al. 2014; Schirch and 
Gross 1968; Shemin 1946). At 0 to 21 days of age, SHMT2 expression in the liver of 
IUGR pigs was much lower (only about 17%) than that in normal piglets. Of note, SHMT2 
expression in the kidneys of IUGR piglets was also low between 0 and 21-days of age. 
The contribution of TDH to glycine synthesis was limited in neonatal piglets. TDH 
activities in the kidney, liver, and pancreas were much lower for IUGR piglets than normal 
piglets. 
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Table 3.1. Relative expression of mRNAs for PRODH2, SHMT2, and TDH in different tissues from normal and IUGR piglets on postnatal days 0, 7, 14 
and 21. 
 
OH-POX   D 0    D 7   D 14   D21 
  Normal IUGR  Normal IUGR  Normal IUGR  Normal IUGR 
Liver  1.00 ± 0.13a 0.11 ± 0.01d  0.63 ± 0.07b 0.19 ± 0.02d  0.59 ± 0.09bc 0.28 ± 0.12d  0.39 ± 0.04bd 0.33 ± 0.03cd 
Kidney  1.00 ± 0.12a 0.35 ± 0.03bc  0.61 ± 0.03b 0.30 ± 0.02bc  0.49 ± 0.11bc 0.36 ± 0.12bc  0.22 ± 0.01c 0.39 ± 0.04bc 
Pancreas  1.00 ± 0.10e 0.32 ± 0.05e  2.06 ± 0.14d 0.90 ± 0.04e  4.81 ± 0.36b 2.97 ± 0.25c  6.13 ± 0.45a 4.85 ± 0.17b 
 Small intestine  1.00 ± 0.08e 0.09 ± 0.01f  1.94 ± 0.22d 0.38 ± 0.03f  4.32 ± 0.22b 3.29 ± 0.21c  5.18 ± 0.28a 4.20 ± 0.23b 
Skeletal muscle   1.00 ± 0.06cd 0.24 ± 0.02e   1.36 ± 0.19bc 0.77 ± 0.08d   1.64 ± 0.17ab 1.06 ± 0.05cd   1.89 ± 0.19a 1.81 ± 0.15a 
             
                                        SHMT     
Liver  1.00 ± 0.04d 0.17 ± 0.02e  2.03 ± 0.18c 0.68 ± 0.08d  4.40 ± 0.11b 1.05 ± 0.13d  5.87 ± 0.26a 4.73 ± 0.30b 
Kidney  1.00 ± 0.05cd 0.88 ± 0.04d  1.42 ± 0.16bc 1.19 ± 0.16cd  1.86 ± 0.16ab 1.83 ± 0.17a  1.91 ± 0.12ab 1.89 ± 0.13ab 
Pancreas  1.00 ± 0.12d 0.75 ± 0.07d  3.06 ± 0.21c 1.05 ± 0.12d  5.17 ± 0.30b 2.69 ± 0.27c  5.76 ± 0.16a 3.12 ± 0.19c 
 Small intestine  1.00 ± 0.17d 0.62 ± 0.02d  3.11 ± 0.09b 0.89 ± 0.06d  5.45 ± 0.27a 2.08 ± 0.22c  5.90 ± 0.33a 2.67 ± 0.21b 
Skeletal muscle   1.00 ± 0.09a 0.07 ± 0.01d   1.02 ± 0.07ab 0.50 ± 0.03c   1.11 ± 0.06a 0.53 ± 0.03c   1.09 ± 0.08a 0.82 ± 0.06b 
             
                                          TDH     
Liver  1.00 ± 0.13d 0.77 ± 0.05d  1.59 ± 0.15bc 1.14 ± 0.19cd  1.91 ± 0.20b 1.59 ± 0.14b  2.51 ± 0.17a 1.93 ± 0.05b 
Kidney  1.00 ± 0.15b 0.12 ± 0.02d  1.42 ± 0.10a 0.13 ± 0.01d  1.48 ± 0.13a 0.33 ± 0.02cd  1.63 ± 0.09a 0.56 ± 0.02c 
Pancreas   1.00 ± 0.11c 0.08 ± 0.01d   1.51 ± 0.10b 0.35 ± 0.02d   2.03 ± 0.11a 0.87 ± 0.10c   2.30 ± 0.20a 1.40 ± 0.13 b 
 
Values are means ± SEM, n = 6 per time point.  a-b means in a row without a common superscript letter differ (P < 0.05) as analyzed by one-way ANOVA 
and the Student–Newman–Keuls (SNK) multiple comparison test.
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Localization and abundances of OH-POX protein in pig tissues 
To investigate if there was a difference in localization and abundances of OH-POX 
protein, we performed immunohistochemical analyses. In the liver of IUGR piglets 
(Figure 3.8), the abundance of OH-POX protein was relatively low compared with normal 
piglets (Chapter II). Interestingly, the age-dependent change in the distribution of the OH-
POX protein found in the different zones of the liver of normal piglets was not observed 
in the liver of IUGR piglets. The localization of the protein was disorganized in livers of 
IUGR piglets, compared with normal piglets. As noted in Chapter II, OH-POX protein 
was localized in the periportal zone at birth, appeared in the transitional zone at 7 days of 
age, and present in the perivenous zone at 21 days of age in normal piglets. In contrast, 
after day 14, the OH_POX protein seemed to be aggregated to the perivenous zone in the 
liver of IUGR piglets. These results suggest that the impairment of hydroxyproline 
catabolism in the liver may be caused by the limited expression of the OH-POX gene. 
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Figure 3.8. The abundance and localization of OH-POX protein in the liver of IUGR piglets at different 
ages. 
 
The IHC results for the kidney of IUGR piglets showed that the OH-POX protein was 
localized in the proximal renal tubule and the abundance increased progressively from day 
0 to day 21 of age. As shown in Figure 3.9, the renal OH-POX protein was expressed 
weakly on day 0, but more abundant after day 14 in IUGR piglets.  
In the small intestine (jejunum), the OH-POX protein was expressed only in 
enterocytes, but not the intestinal glands (crypts) (Figure 3.10, day 0 of age). However, at 
days 14 and 21 of age, OH-POX protein was expressed in both enterocytes and the 
intestinal glands (crypts). Epithelial cells and glands are the major sites of both nutrient 
absorption and protein secretion in the small intestine. These results indicate increased 
expression and activities of OH-POX in the small intestine during the suckling period.  
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Figure 3.9. The abundance and localization of OH-POX protein in the kidney of IUGR piglets at 
different ages. 
 
 
 
Figure 3.10. The expression and localization of OH-POX in the small intestine (jejunum) of IUGR 
piglets at different ages. 
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Unlike normal piglets, no OH-POX protein was detected in the pancreas, cardiac 
muscle, skeletal muscle, or stomach of IUGR piglets. Thus, tissue distribution of the OH-
POX protein differed between normal and IUGR piglets. 
Discussion 
Unlike for other mammals, glycine is the most abundant amino acid in plasma of 
neonatal pigs (~1-1.2 mM), in comparison to 0.2-0.3 mM in plasma of other mammals 
(Wang et al. 2013a). However, as noted previously, concentrations of glycine in plasma 
of neonatal IUGR piglets is only about 0.6 mM. Considering the important physiological 
roles of glycine in purine synthesis, protein synthesis, one-carbon unit metabolism, 
cytoprotection (especially for liver cell and enterocytes in GI tract), anti-oxidation, and 
anti-inflammation (Jacob et al. 2003; Sun et al. 2016b; Wu 2013b), a deficiency in glycine 
may be one of the main factors contributing to high mortality rates and growth restriction 
in IUGR piglets (Wang et al. 2014a; Wu et al. 2014; Wu et al. 2013). At present, little is 
known about mechanisms responsible for glycine deficiency in IUGR neonates. OH-POX, 
serine hydroxymethyl transferase, and threonine dehydrogenase are key enzymes for the 
synthesis of glycine from hydroxyproline, serine, and threonine, respectively (Chao et al. 
1953; Lowry et al. 1985a; Shemin 1946), respectively. Only by analyzing the expression 
of these enzymes, can we have an overall understanding of the capacities of tissues for 
endogenous glycine synthesis via different pathways in piglets. As discussed in Chapter 
II, the hydroxyproline-Gly pathway is primarily responsible for glycine synthesis in 
neonatal pigs. This pathway is seriously impaired in tissues of IUGR piglets. Similarly, 
the capacities for glycine synthesis via the threonine-glycine and the serine-glycine 
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pathways are much lower in the liver and kidneys of IUGR piglets, compared with normal 
piglets.  
It should be borne in mind that rates of product formation in tissues are true indicators 
of the activities of their metabolic pathways, including the hydroxyproline-glycine 
pathway. This is because the measurement of enzymatic activity is performed under 
optimal conditions, such as saturated concentrations of substrates, which do not occur in 
tissues under physiological conditions.  For this reason, the rate of glycine synthesis from 
hydroxyproline in tissues of IUGR and normal pigs must be determined. The localization 
of enzyme proteins in the liver is a determinant of their physiological functions. For 
normal piglets, OH-POX is expressed in the periportal zone of the liver in the first week 
of postnatal life to produce glycine (Chapter II). In contrast, this zonation of the OH-POX 
protein was not clearly observed in the liver of IUGR piglets. Rather, this protein was 
aggregated in the perivenous zone at 21 days of age. Because of the lack of the OH-POX 
protein in the periportal zone, the liver may contribute little or no glycine to IUGR piglets. 
In vivo measurement of glycine flux through the liver is required to test this hypothesis. 
Besides the OH-POX-glycine pathway, the SHMT-glycine pathway is also impaired 
in IUGR pigs. This can be classified as “inborn errors of glycine synthesis” in pigs, which 
is a novel concept in amino acid metabolism. The pig, a polytocous animal, has a higher 
rate of IUGR occurrence than other livestock species. Limited uterine capacity results in 
an insufficient supply of nutrients and oxygen from mother to fetus. Increasing placental 
angiogenesis and growth is an effective means for enhancing fetal growth and 
development. We recently found that glycine promotes the transport of water and amino 
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acids by the porcine placenta (Hu et al. 2017, abstract). Thus, future studies are warranted 
to determine whether dietary supplementation with glycine may stimulate the glycine-
synthetic pathways and improve embryonic and fetal development of mammals (including 
pigs). 
In conclusion, results of the present study indicated that the enzymatic activities of 
OH-POX and SHMT were much lower in the liver and kidneys of IUGR piglets between 
days 0 and 14 of age, compared with normal pigs. The enzymatic activity of TDH in these 
two tissues did not differ between IUGR and normal piglets. Similar results were obtained 
for expression of mRNAs for those enzymes. The abundance of the OH-POX protein was 
low in the liver, small intestine, and skeletal muscle. Furthermore, there was no zonation 
of the OH-POX protein in the liver of IUGR piglets, possibly leading to a low net rate of 
glycine synthesis by the liver. These novel findings provide a biochemical basis to explain 
why the endogenous synthesis of glycine is insufficient for maximal growth of sow-reared 
IUGR piglets. This new foundational knowledge can be utilized to improve the growth, 
development, and survival of IUGR piglets worldwide. 
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CHAPTER IV 
GLYCINE SUPPLEMENTATION ACTIVATES THE MTOR CELL 
SIGNALING IN SKELETAL MUSCLE AND ENHANCES THE GROWTH OF  
NEONATAL PIGLETS 
 
This study was conducted to evaluate a role for glycine in the growth of both normal 
and low birth weight piglets reared by sows. Eighty newborn piglets (postnatal day 0), 
including 40 normal birth-weight piglets, body weight (BW) ≥ 1.10 kg, and 40 low birth-
weight piglets (IUGR), BW < 1.10 kg, were allotted randomly into one of four treatment 
groups (10 normal birth-weight and 10 low birth-weight piglets in each group). Piglets 
received oral administration of either 0, 0.1, 0.2 or 0.4 g glycine per kg BW twice daily 
between 1 and 14 days of age. Alanine was used as the isonitrogenous control. The body 
weights of all piglets were recorded each week during the experiment. Two weeks after 
the initiation of glycine supplementation, blood and tissue samples were collected for 
biochemical assays. Results were analyzed statistically using one-way ANOVA. 
Compared with control piglets, oral administration of 0.2, 0.4 and 0.8 g glycine/kg BW 
per day enhanced (P < 0.05) concentrations of glycine and serine in plasma, as well as 
weight gain in piglets, with the dose of 0.4 g glycine/kg BW being the most effective. 
Consistent with its growth-promoting effect, glycine supplementation augmented the 
phosphorylation of mechanistic target of rapamycin (MTOR), eukaryotic initiation factor 
4E binding protein 1 (4E-BP1) and p70S6 kinase (p70S6K) in skeletal muscle, compared 
with the control group. Collectively, oral administration of glycine activated the MTOR 
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signaling pathway in skeletal muscle and enhanced growth performance of newborn 
piglets, especially those with a low birth weight. The results also indicated that 
endogenous synthesis of glycine is inadequate to meet the metabolic needs of piglets with 
a low or normal birth weight. 
Introduction 
In both the fetus and the neonate, glycine has the greatest rate of deposition among all 
amino acids (Wu et al. 2014). Thus, dietary requirements of animals for glycine are 
particularly high during any phase of animal life (Hu et al. 2016; Wu 2009; Wu et al. 
2014). This is consistent with multiple roles of glycine in cell signaling, metabolism, and 
function, including activation of the mechanistic target of rapamycin (MTOR) cell 
signaling pathway in skeletal muscle (Jackson 1991; Mudd et al. 2007; Wang et al. 2013a). 
Traditionally, glycine was classified as a “non-essential amino acid” for mammals, 
because it can be synthesized from serine (Shemin 1946), threonine (Chao et al. 1953), 
and choline (Soloway and Stetten 1953). However, growing evidence shows that the 
amount of endogenously synthesized glycine is insufficient to meet the metabolic 
requirements for humans, pigs, rodents, and birds (Jackson 1991; Wang et al. 2013a; 
Wang et al. 2014c; Wu and Knabe 1994). Therefore, glycine should be considered as a 
“conditionally essential amino acid” for animal growth, development, and health. 
Intrauterine growth restriction (IUGR) is a major problem in swine production 
worldwide (Wu et al. 2006). Up to 25% of pigs are born with a body weight of less than 
1.1 kg. Without effective nutritional management, neonatal pigs with IUGR grow at a 
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slower rate and have a lower feed efficiency and higher mortality than littermates with a 
normal birth weight (Ji et al. 2017). Thus, IUGR piglets are often culled on farms, and this 
represents huge economic losses to producers. Wang et al. (2014) reported that dietary 
supplementation with glycine improved the growth performance of milk-fed piglets with 
a normal birth weight. Whether this treatment can be applicable to IUGR piglets is 
unknown, because they may respond differently to the same nutrient (e.g., leucine or 
protein) than piglets with a normal birth weight (Sun et al. 2015). For example, doubling 
protein intake by 50% promotes muscle growth in piglets with a normal birth weight, but 
causes high rates of morbidity and mortality in piglets with IUGR (Jamin et al. 2010).  
The objective of this study was to test the hypothesis that oral administration of glycine 
to sow-reared IUGR piglets could stimulate MTOR cell signaling and whole-body growth. 
Materials and methods 
Pigs  
The experimental protocol of this study was approved by the Texas A&M University 
Institutional Animal Care and Use Committee. All animals were maintained at the Texas 
A&M University Swine Center. 
Eighty newborn piglets were selected from 10 sows, and piglets were the offspring of 
Yorkshire x Landrace sows bred to Duroc boars. The average litter size of sows was 12 at 
birth. Throughout the lactation period, sows had free access to water and a corn-soybean 
meal-based diet that met the recommended NRC requirements (Table 4.1). Immediately 
after farrowing, all newborn piglets (day 0 of age) were weighted. Forty normal birth 
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weight piglets (normal, BW ≥ 1.1 kg), and 40 low birth weight piglets (IUGR, BW < 1.1 
kg) were selected. Normal birth weight piglets or IUGR piglets were assigned randomly 
into one of four groups (10 piglets/group).  
Experimental design 
Beginning on the day of birth (day 0), immediately after nursing, piglets received oral 
administration of 0.1, 0.2, 0.4 g glycine/kg BW twice daily (in the morning and evening) 
for 14 days. L-alanine was used as the isonitrogenous control. Glycine or alanine was 
dissolved in 10 ml drinking water before gavaging. Piglets were weighed at days 0, 7 and 
14 of age.  
Blood sample collection and analysis of amino acids in plasma 
On day 14 of the experiment, 6 piglets in each group were randomly selected and 
fasted for 1.5 h. Jugular vein blood samples (5 ml) were withdrawn from each animal into 
an EDTA-containing tube. The blood samples were centrifuged immediately at 10,000 
rpm for 1 min, and the supernatant fluid (plasma) was stored at -80°C until analyzed. 
Amino acids in plasma were analyzed by HPLC methods, as previously described (Hu et 
al. 2015; Wu et al. 1997; Wu and Knabe 1994; Wu and Meininger 2008). 
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Table 4.1. Composition of the diet for lactating sows (as-fed basis) 
 
Item        Diet1, % 
Ingredient 
 Corn grain         57.50  
 Soybean meal, 44.5% CP       27.00  
 Cornstarch       2.0 
 Sugarcane molasses      3.85 
 Potassium chloride        0.10  
 Salt          0.35  
 Vitamin-mineral premix2       3.00  
 Vegetable oil         3.00  
 Dicalcium phosphate        2.50  
 Limestone         0.70  
 
Chemical composition 
 Dry matter, %         90.0  
 Metabolizable energy, Mcal/kg       3.32  
 Crude protein3, %        17.5  
 Calcium, %         1.04  
 Available phosphorus, %       0.54  
 Total phosphorus, %        0.79  
 
1 This lactation diet was provided to sows ad libitum from farrowing. 
2The vitamin premix provided the following per kg of complete diet (as-fed basis): 46.7 mg of Mn as 
manganous oxide; 75 mg of Fe as iron sulfate; 103.8 mg of Zn as zinc oxide; 9.5 mg of Cu as copper sulfate; 
0.72 mg of I as ethylenediamine dihydroiodide; 0.23 mg of Se as sodium selenite; 7,556 IU of vitamin A as 
vitamin A acetate; 825 IU of vitamin D3; 61.9 IU of vitamin E; 4.4 IU of vitamin K as menadione sodium 
bisulfate; 54.9 µg of vitamin B12; 13.7 mg of riboflavin; 43.9 mg of D-pantothenic acid as calcium 
pantothenate; 54.9 mg of niacin; and 1,650 mg of choline as choline chloride. 
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Collection of tissues from piglets. 
On day 14 of the experiment, after blood sampling, piglets were anesthetized with an 
intramuscular injection of Telazol (10 mg/kg BW) and then euthanized by intra-cardiac 
administration of saturated KCl. Skeletal muscle (Latissimus dorsi muscle) was quickly 
isolated and cut into small pieces which were frozen in liquid nitrogen, and stored at -
80°C.  
Western blot analysis     
The frozen muscle tissue was ground to powder under liquid nitrogen and then 
homogenized in the lysis buffer containing 20 mM Tris-HCl (pH 7.4), 50 mM NaCl, 50 
mM NaF, 50 mM of EDTA, 1% Triton X-100, 1x protease inhibitor cocktail, and 1x 
phosphatase inhibitor cocktail (Calbiochem, La Jolla, CA). Proteins in homogenates were 
analyzed using the bicinchoninic acid assay (BCA) method, and the samples were 
subsequently diluted with 2x Laemmli buffer (125 mM Tris-HCl pH 6.8, 4% w/v SDS, 
10% 2-mercaptoethanol, 12% glycerol, and 0.004% w/v bromphenol blue) and heated in 
boiling water for 5 min. Aliquots of samples were loaded onto SDS-polyacrylamide gels. 
After separation on 4-12% gels, proteins were transferred to a nitrocellulose membrane 
(Bio-Rad, Hercules, CA) under 12V overnight, using the Bio-Rad Transblot apparatus 
(Hercules, CA). Membranes were blocked in 5% fat-free dry milk in TTBS (20 mM 
Tris/150 mM NaCl, pH 7.5, and 0.1% Tween-20) for 3 h and then incubated with one of 
the following primary antibodies overnight at 4 oC with gentle rocking: MTOR (Cell 
Signaling, 1:1000), phosphorylated MTOR (Cell Signaling, 1:1000), 4E-BP1 (Cell 
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Signaling, 1:1000), phosphorylated 4E-BP1 (Cell Signaling, 1:1000), p70S6 Kinase (Cell 
Signaling, 1:1000), or phosphorylated p70S6 Kinase (Cell Signaling, 1:1000). After being 
washed three times with TTBS, the membranes were incubated at room temperature (25 
oC) for 2-3 h with a secondary antibody at 1: 50,000 (peroxidase-labeled donkey anti-goat 
or anti-rabbit IgG, Jackson Immuno Research). Finally, the membranes were washed with 
TTBS, followed by development using the Super Signal West Dura Extended Duration 
Substrate according to the manufacturer’s instructions (Pierce, Rockford, IL). The signals 
were detected on Fujifilm LAS-3000 (Tokyo, Japan).  
Results 
Body weight gain of piglets 
Table 4.2 summarizes the effects of oral administration of glycine to IUGR piglets on 
their growth performance. Based on body weight gain, the supplemental dose of 0.4 g 
glycine/kg BW yielded the most effective result. Glycine supplementation (0 to 0.4 g/kg 
BW) increased body weight in a dose-dependent manner. However, the growth rate of 
piglets receiving 0.8 g glycine/kg BW tended to be lower than that for the 0.4 g glycine/kg 
BW group. Based on body weight gain, the supplemental dose of 0.4 g glycine/kg BW 
yielded the most effective result. Glycine supplementation also had a beneficial effect on 
the growth of piglets with a normal birth weight (Table 4.3). Specifically, the average 
daily weight gain (ADG) in the first week and the second week was 155 and 149 g 
respectively, in the control group, compared to 210 g and 168 g, respectively, in the 0.4 g 
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glycine/kg BW group. As in IUGR piglets, the growth rate of normal birth weight piglets 
receiving 0.8 g /kg BW tended to be lower than that for the 0.4 g glycine/kg BW group.  
 
Table 4.2. The effects of oral administration of glycine on the body weight of IUGR piglets (kg, n=10) 
 
Day 0 Day 7 Day 14 
Control 0.86 ± 0.07 1.63 ± 0.08a 2.30 ± 0.12a 
0.2 g Glycine / kg BW per day 0.88 ± 0.02 1.88 ± 0.06b 2.76 ± 0.08b 
0.4 g Glycine / kg BW per day 0.85 ± 0.04 2.07 ± 0.05b 3.16 ± 0.14c 
0.8 g Glycine / kg BW per day 0.88 ± 0.04 2.01 ± 0.08b 3.07 ± 0.07c 
 
Different doses of glycine were administered orally to IUGR piglets between days 0 and 14 of life.  
Values are means ± SEM, n = 10 per group. Means in a column without a common superscript letter differ 
(P < 0.05) as analyzed by one-way ANOVA and the Student-Newman-Keuls (SNK) multiple comparison 
test. 
 
Concentrations of amino acids in plasma  
Glycine supplementation increased the concentrations of glycine in the plasma of 
neonatal piglets. Compared with the control group, supplementation with 0.2, 0.4, and 
0.8g/kg glycine per kilogram body weight increased concentrations of glycine in plasma 
in a dose-dependent manner, by 1.52-, 1.94-, and 2.34- fold (P < 0.05), respectively 
(Figure 4.1). Concentrations of serine also increased in glycine treated piglets (P < 0.05). 
Concentrations of other amino acids in plasma (including arginine, aspartate, glutamate, 
histidine, hydroxyproline, lysine, ornithine, and proline) did not differ among the 
treatment groups of piglets.  
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Table 4.3. The effects of oral administration of glycine on the body weight of normal birth weight piglets 
(kg, n=10) 
 
 
Day 0 Day 7 Day 14 
Control 1.30 ± 0.06 2.39 ± 0.07a 3.43 ± 0.12a 
0.2 g Glycine / kg BW per day 1.32 ± 0.05 2.55 ± 0.11ab   3.62 ± 0.08ab 
0.4 g Glycine / kg BW per day 1.29 ± 0.02 2.76 ± 0.05b 3.94 ± 0.07c 
0.8 g Glycine / kg BW per day 1.30 ± 0.05 2.59 ± 0.08ab 3.72 ± 0.04bc 
 
Different doses of glycine were administered orally to normal birth weight piglets between days 0 and 14 of 
life.  
Values are means ± SEM, n = 10 per group. a-b Means in a column without a common superscript letter 
differ (P < 0.05) as analyzed by one-way ANOVA and the Student-Newman-Keuls (SNK) multiple 
comparison test. 
 
Proteins in the MTOR cell signaling pathway in skeletal muscle  
Western-blot analyses revealed that glycine supplementation induced the 
phosphorylation of MTOR pathway proteins, including MTOR, p70S6K, and 4E-BP1, 
without altering expression of MTOR, p70S6K, and 4E-BP1 proteins. 
The expression of phosphorylated MTOR was 4.85 times greater in piglets receiving 
the 0.4 g glycine supplementation than for control piglets (P < 0.05, Figure 4.2). The 4E-
BP1 and p70S6K proteins also had a high-level of phosphorylation in response to 
supplemental glycine (P < 0.05, Figures 4.3 and 4.4). 
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Figure 4.1. Plasma glycine, serine, and alanine concentrations in IUGR piglets. 
 
Table 4.4. Plasma amino acid concentrations in IUGR piglets.  
 
Amino acids  
(nmol/mL) Control 0.2 g glycine/kg BW 0.4 g glycine/kg BW 0.8 g glycine/kg BW   
Aspartic acid 14.1 ± 1.6 15.3 ± 1.7 14.7 ± 1.7 16.0 ± 2.5  
Glutamate 189 ± 11.5a 161 ± 10.9ab 144 ± 8.91b 137 ± 9.60b  
Asparagine 82.2 ± 6.1 83.4 ± 6.3 79.5 ± 9.9 75.2 ± 5.7  
Serine 278 ± 12.5a 312 ± 8.56b 328 ± 11.7b 347 ± 6.79b  
Glutamine 654 ± 18.4a 547 ± 19.0b 478 ± 20.5c 455 ± 4.90c  
Histidine 67.2 ± 4.34 65.4 ± 3.37 64.6 ± 5.32 67.9 ± 7.18  
Glycine 586 ± 10.3a 890 ± 17.1b 1134 ± 18.9c 1382 ± 21.5d  
Threonine 154 ± 7.65a 171 ± 6.11ab 189 ± 11.4b 194 ± 10.7b  
Citrulline 132 ± 4.09 136 ± 7.06 129 ± 7.72 134 ± 11.6  
Arginine 172 ± 13.2 174 ± 10.3 181 ± 8.09 179 ± 12.7  
-Alanine 14.6 ± 2.17 14.1 ± 1.61 13.8 ± 1.03 14.4 ± 1.50  
Taurine 124 ± 2.66 126 ± 10.72 129 ± 5.39 127 ± 3.80  
Alanine 903±9.60a 627±6.12b 613±8.47b 615±7.56b  
Tyrosine 154 ± 7.24 149 ± 4.71 156 ± 9.05 157 ± 8.23  
Tryptophan 76.0 ± 5.14 73.2 ± 2.92 72.2 ± 5.61 76.1 ± 4.14  
Methionine 60.1 ± 4.11 62.5 ± 5.27 67.5 ± 7.72  66.9 ± 4.93  
Valine 210 ± 9.06 211 ± 5.09 216 ± 6.31 218 ± 4.20  
Phenylalanine 71.5 ± 4.96 64.0 ± 3.90 71.0 ± 8.65 74.3 ± 5.77  
Isoleucine 106 ± 5.81 112 ± 4.70 107 ± 9.43 110 ± 8.18  
Leucine 151 ± 6.82 155 ± 3.97 153 ± 6.46 148 ± 8.41  
Ornithine 114 ± 8.46 119 ± 6.25 115 ± 12.2 111 ± 6.30  
Lysine 136 ± 11.4 141 ± 9.36 149 ± 10.6 153 ± 8.97   
 96 
 
 
Figure 4.2. Abundances of MTOR and phosphorylated MTOR proteins in the skeletal muscle of IUGR 
piglet receiving oral administration of glycine. GAPDH protein was used as the internal control. Values are 
means ± SEM, n = 6 per group. * P < 0.05: different from the control group (P < 0.05).  
 
 
Figure 4.3. Abundances of 4E-BP1 and phosphorylated 4E-BP1 proteins in skeletal muscle of IUGR 
piglets receiving oral administration of glycine. GAPDH protein was used as the internal control. Values are 
means ± SEM, n = 6 per group. * P < 0.05: different from the control group (P < 0.05). 
 
 
Figure 4.4. Abundances of p70S6K and phosphorylated p70S6K proteins in skeletal muscle of IUGR 
piglets receiving oral administration of glycine. GAPDH protein was used as the internal control. Values are 
expressed as means ± SEM, n = 6 per group. * P < 0.05: different from the control group (P < 0.05). 
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Discussion 
Glycine has versatile roles in nutrition, metabolism, and health. It was classified as a 
“non-essential amino acid” for mammals, but this term has now been recognized as a 
misnomer (Hou and Wu 2017). Several lines of evidence have documented the beneficial 
effects of glycine on the maintenance and growth of mammals with a normal birth weight. 
First, glycine regulates the expression and distribution of mucosal barrier proteins 
(claudin-7 and ZO-3) in intestinal epithelial cells (Li et al. 2016). Second, glycine 
stimulates protein synthesis and inhibits proteolysis in skeletal muscle (Sun et al. 2016a), 
which is of enormous importance in both animal agriculture and human health (Hou et al. 
2016). The underlying mechanisms involve the activation of the MTOR cell signaling 
(Ham et al. 2016; Koopman et al. 2017; Ost et al. 2015; Sun et al. 2016a) and reduced 
expression of pro-inflammatory cytokines (Liu et al. 2016). Third, dietary 
supplementation with glycine enhanced the growth performance and feed efficiency of 
milk-fed piglets (Wang et al. 2014a) and post-weaning piglets. To our knowledge, this is 
the first report regarding effects of glycine supplementation on the growth of sow-reared 
IUGR piglets.  
Glycine is deficient in IUGR piglets, as its concentration in their plasma is only half 
that in normal piglets at days 1 and 7 of age. Insufficient endogenous synthesis of glycine 
(Chapter II) may contribute, in part, to growth restriction in IUGR neonates. A novel and 
important finding from this work is that oral administration of glycine to normal and IUGR 
piglets enhanced their growth, with the dose of 0.4 g glycine/kg BW being the most 
effective. Interestingly, in contrast to supplementation with leucine (Sun et al. 2015) or 
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protein (Jamin et al. 2010), both normal and IUGR piglets responded similarly to oral 
administration of glycine with an improvement of lean tissue gain. It is possible that most 
of the supplemental glycine is used for whole-body protein synthesis and, therefore, only 
a small amount of glycine is oxidized to generate ammonia in all of the neonates. Hence, 
no toxicity occurs in association with glycine supplementation. In this regard, glycine 
offers an advantage over leucine or protein as a nutritional supplement to IUGR neonates, 
although both amino acids can activate MTOR cell signaling and protein synthesis in 
skeletal muscle. Our results also provide another line of evidence to support the notion 
that endogenous synthesis of glycine is insufficient for maximal growth and feed 
efficiency in young pigs. 
 The MTOR signaling pathway is the master regulator of protein biosynthesis, as well 
as cell growth and cytoskeleton remodeling (Dennis et al. 2011; Wu 2013b). Skeletal 
muscle development is highly dependent on MTOR activation. The MTOR system 
consists of two components: MTOR complex 1 (MTORC1) and MTOR complex 2 
(MTORC2). Both of MTORC1 and MTORC2 can be activated by an upstream protein 
kinase (Kim and Guan 2011; Sun et al. 2016a). Activated MTOR phosphorylates two 
downstream target proteins: S6K1 and 4E-BP1. The cell signaling cascade initiated by 
MTOR phosphorylation leads to protein synthesis in tissues (including skeletal muscle) 
(Dennis et al. 2011; Kim and Guan 2011). Results of the present study indicated that 
glycine supplementation to neonatal IUGR piglets enhanced the phosphorylation of 
MTOR, p70S6K, and 4E-BP1 proteins in skeletal muscle, as reported for muscle cells (Sun 
et al. 2016; Liu et al. (2016). Glycine is virtually not degraded by muscle cells (Wu 2013). 
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Therefore, it is unlikely that a metabolite of glycine mediates its effect on MTOR 
activation. We propose that glycine binds to MTOR and alters the configuration of the 
protein kinase. This would be analogous to the binding of glycine to the glycine receptor 
in the central nervous system, thereby modulating neurotransmission 
(Yevenes and Zeilhofer 2011). Thus, the possibility that glycine is an allosteric activator 
of MTOR should be examined in future studies. 
In conclusion, oral administration of glycine (0.2, 0.4 and 0.8 g/kg BW per day) 
enhanced growth performance in both normal birth weight and IUGR piglets. Glycine 
activated the MTOR cell signaling pathway to promote the net deposition of protein in 
skeletal muscle and the whole body. At the supplemental doses, all piglets tolerated 
glycine with no side effects. These results indicate a functional role for glycine in 
metabolism and support the view that endogenous synthesis of glycine in young pigs 
cannot meet their metabolic needs for maximal growth. 
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CHAPTER V 
SUMMARY AND DIRECTION OF FUTURE RESEARCH 
 
Glycine is one of the most abundant amino acids in animals and it plays vital roles in 
nutrition, metabolism, reproduction, and health. However, sow’s milk provides at most 
less than 30% of the metabolic needs for glycine by suckling piglets. Therefore, 
endogenous synthesis of glycine must exist in young pigs to support their growth and 
development. Serine, threonine, and choline are substrates for glycine synthesis in the 
liver, but these pathways contribute only a small amount of glycine to sow-reared piglets 
due to the limited provision of the glycine precursors from milk. New endogenous 
source(s) of glycine in pigs remain to be identified. A series of experiments were 
conducted to fill in this gap of knowledge.  
The major purpose of this dissertation research was to investigate the novel 
endogenous glycine synthesis pathway. A substantial body of literature documented a new 
function for dietary glycine in improving growth performance of young pigs and 
ameliorating cell injury (Wang et al. 2013a; Wu et al. 2014). For example, dietary glycine 
supplementation to sow-reared piglets is necessary for them to realize their maximal 
growth potential (Powell et al. 2011; Wang et al. 2014c). Results of this dissertation 
research indicate that the amount of endogenously synthesized glycine does not meet the 
metabolic requirements by sow-reared piglets.  
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The first part of this study was designed to investigate a role of hydroxyproline (an 
abundant amino acid in sow’s milk and plasma of piglets) in glycine synthesis by tissues 
of newborn piglets (Chapter II). Neonatal piglets at 0, 7, 14 and 21 days of age were used. 
The enzymatic activities, as well as expression of mRNAs and abundances of the 
hydroxyproline-glycine pathway proteins, including OH-POX, POX, AGT, and HOA, 
were present in the liver and kidneys at birth and during the suckling period. These 
enzymes were expressed at lower levels in the pancreas, small intestine, and skeletal 
muscle of 14- to 21-day-old pigs. Based on the mass of tissues, we conclude that the liver 
(mainly periportal hepatocytes) and kidneys play an important role in glycine synthesis in 
piglets during the first days of their postnatal life. As pigs grew toward weaning, hepatic 
OH-POX was expressed mainly in the perivenous hepatocytes (a small population of 
hepatocytes), the small intestine and the skeletal muscle became the major sites of glycine 
synthesis from hydroxyproline. The coordination of multiple organs maximizes net 
glycine production by piglets. 
The concentration of glycine in the plasma of IUGR piglets was much lower than that 
in normal birth weight piglets. This raised a question of whether glycine synthesis was 
reduced in IUGR piglets. Thus, the second part of the research investigated glycine 
synthesis from hydroxyproline by tissues of IUGR piglets (Chapter III). The activities of 
OH-POX and SHMT were lower in the liver, kidneys and other tissues of IUGR piglets, 
compared with normal birth weight pigs. The activity of TDH did not differ between IUGR 
and normal piglets. Similar results were obtained for expression of mRNAs for those 
enzymes in a tissue-specific manner. The capacity for the conversion of hydroxyproline 
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into glycine in the tissues of IUGR piglets was only about 10% of that for normal piglets. 
Collectively, these novel results provide the first line of evidence that endogenous 
synthesis of glycine is impaired sow-reared pigs piglets.  
Subsequent experiments were conducted to evaluate the role of endogenous synthesis 
of glycine in growth of piglets (Chapter IV). Particularly, glycine supplementation was 
used as a tool to assess whether glycine synthesis may limit lean tissue gain in both IUGR 
and normal piglets. Both types of piglets responded well to oral administration of 0.4 g 
glycine/kg BW with improved growth performance. This is in contrast to the reported 
adverse effects of leucine or protein supplementation on IUGR piglets, which include high 
rates of morbidity and mortality possibly due to ammonia toxicity. It is likely that most of 
the supplemental glycine is used for protein synthesis rather than oxidation to ammonia 
and CO2. Consistent with its growth-promoting effect, glycine supplementation enhanced 
the phosphorylation of mechanistic target of rapamycin (MTOR), eukaryotic initiation 
factor 4E binding protein 1 (4E-BP1) and p70S6 kinase (p70S6K) in skeletal muscle, 
leading to an increase in net protein synthesis by the tissue. Collectively, these findings 
indicate that glycine is a signaling molecule that has vital roles in young pigs and that the 
endogenous synthesis of glycine is insufficient for maximal growth in the neonatal pig. 
Future studies are needed to better understand the metabolic zonation of glycine-synthetic 
enzymes in the liver and the molecular mechanisms responsible for differential expression 
of OH-POX in hepatocytes with age. It will also be of interest to investigate relationships 
between low rates of glycine synthesis (low levels of enzyme expression) and malnutrition 
in IUGR piglets. Finally, a role for glycine in placental growth, development, and 
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angiogenesis warrants studies, with the hope of preventing intrauterine growth restriction 
(IUGR) in pigs. Finally, because glycine is involved in one-carbon unit metabolism and, 
therefore, methylation of genes and proteins, it is imperative to determine whether 
supplementing glycine to gestating swine or neonatal pigs may affect epigenetic 
modifications and have carry-on effects to improve growth performance and feed 
efficiency of offspring. Collectively, the novel findings from this dissertation provide a 
biochemical basis for the classification of glycine as a nutritionally essential amino acid 
for young pigs and revision of the century-old nutritional concept that dietary glycine is 
not needed by mammals. Findings from the current study not only advance basic 
knowledge of nutritional biochemistry, but also have important implications for 
developing practical means to enhance pig production in the animal industry. Finally, 
because the pig is an excellent model for studying human nutrition and metabolism, results 
from this dissertation research may be used to formulate new diets for IUGR human 
infants.
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APPENDIX 
 
A1.  Preparation of Tissue Homogenates for Enzyme Assays 
 
Chemicals. 
1. 5 mM Hepes (pH 7.4):  Dissolve 596 mg Hepes (Sigma, Cat. #H-3375) in 480 ml 
H2O.  Adjust to pH 7.4 with 10 M NaOH. Makeup to final volume 500 ml with H2O. 
2. 300 mM Sucrose/1 mM EDTA/5 mM Hepes (pH 7.4):  Dissolve 51.4 g sucrose and 
186 mg EDTA (disodium) in 500 ml of 5 mM Hepes buffer (pH 7.4).  
3. A stock solution of protease inhibitors (2.5 mg/ml each): Dissolve 2.5 mg aprotinin, 
2.5 mg chymostatin, 2.5 mg pepstatin A, and 2.5 mg phenylmethylsulfonylflouride 
in 1 ml of dimethyl sulfoxide. 
3. Homogenization buffer (300 mM sucrose/1 mM EDTA/5 mM Hepes/3 mM 
DTT/0.5% Triton X-100, pH 7.4):  Mix 30 ml of 300 mM sucrose/1 mM EDTA/5 
mM Hepes solution (pH 7.4), 30 μl stock solution of protease inhibitors, 15 mg 
dithiothreitol, and 0.15 ml Triton X-100. 
 
Tissue homogenization:   
1. Rinse a fresh tissue twice with saline (0.9% NaCl) to remove blood.   
2. Obtain a sample of ~0.5 g.   
3. Homogenize the sample (~0.5 g) in 2 ml of homogenization buffer.   
4. Transfer the 2-ml homogenates to a tube.   
5. Rinse the homogenizer with 3 ml of the homogenization buffer, and transfer it to the 
tube containing the previous 2-ml homogenates.   
6. The combined homogenates are centrifuged at 3000 g, 4oC for 5 min, and the 
supernatant fluid is used for enzyme assay.  This supernatant fluid is stored at -80oC. 
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A2.  Determination of 4-Hydroxy-2-Oxoglutarate Aldolase Activity 
 
Chemicals. 
1. Buffer:  100 mM potassium phosphate (KPi) buffer (pH 7.8) 
2. Substance: 100 mM DL-4-hydroxy-2-ketoglutarate (disodium salt)  
 
Assay procedures 
1. To each tube, add the following: 
  Sample tube    Blank tube 
  0.6 mL buffer    0.6 mL buffer 
  0.2 mL Tissue homogenate  0.2 mL Tissue homogenate 
  0.2 mL H2O    0.2 mL H2O 
 Warm up to 37oC  
  0.2 mL 100 mM H.O.A  0.2 mL H2O 
  
2. After 0.5, 5.5, and 10.5 min, remove 0.3 mL from system into 0.3 mL 10% TCA 
3. Centrifuge 2500 rpm for 10 min, acquire the supernatant 
4. Measure the pyruvate production by following pyruvate analysis protocol 
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A3.  Determination of Alanine: Glyoxylate Transaminase Activity 
 
Chemicals. 
1. Buffer:  100 mM KPi buffer (pH 7.4) 
2. Substance: 100 mM glyoxylic acid 
Alanine: 100 mM   
 
Assay procedures 
1. To each tube, add the following: 
  Sample tube    Blank tube 
  0.25 mL buffer   0.25 mL buffer 
  0.1 mL Glyoxylic acid  0.1 mL H2O 
  0.1 mL H2O    0.1 mL H2O 
 Warm up to 37oC  
  0.02 mL Tissue homogenate  0.02 mL Tissue homogenate 
  
2. After 20 min incubation, stop the reaction by using 0.5 mL 10% TCA 
3. Centrifuge 2500 rpm for 10 min, and acquire the supernatant 
4. Measure pyruvate production by following pyruvate analysis protocol 
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A4.  Determination of Hydroxyproline Oxidase Activity 
 
Chemicals. 
 
1. Buffer:  80 mM KPi  (pH 8.0) with 16 uM Cytochrome: 
Dilute 4 mg Type III Cytochrome C into 20 mL buffer 
2. Substance: 600 mM 4-hydroxy-L-Proline. Dissolve 0.787 g 4-hydroxy-L-proline 
into 10 mL H2O  
3. Reaction reagent: Dissolve 40 mg O-aminobenaldehyde into 16 mL 100% 
ethanol thoroughly, and combine the ethanol with 24 mL 10% TCA 
 
Assay procedures 
1. To each tube, add the following: 
System:  Sample tube     Blank tube 
  1.5 mL Buffer     1.5 mL Buffer 
  0.75 mL Hydroxyproline   0.75 mL H2O 
  0.45 mL H2O     0.45 mL H2O 
 Warm up to 37oC  
  0.3 mL Tissue homogenate    0.3 mL Tissue homogenate 
2.  After 0, 15, and 30 min, remove 0.8 mL from the assay solution into 1.6 mL 
reaction reagent 
3. Leave the tube for at least 30 min at room temperature, and centrifuge the tube at 
2500 rpm for 10 min.  Acquire the supernatant fluid. 
4. Measure the absorbance of the supernatant fluid at 443 nm. 
Calculation: 
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A5.  Determination of Proline Oxidase Activity 
Chemicals 
1. 50 mM Potassium Phosphate Buffer (pH 7.2): 
 a) 50 mM K2HPO4: Dissolve 8.7 g of K2HPO4 in 1 L of deionized H2O. 
 b) 50 mM KH2PO4: Dissolve 6.8 g of KH2PO4 in 1 L of deionized H2O. 
 c) 50 mM Potassium Phosphate Buffer (pH 7.2):   
 d) 50 mM Potassium Phosphate Buffer (pH 7.5):   
2. 30 mM Proline: Dissolve 35 mg proline in 10 ml of 50 mM potassium phosphate 
buffer (pH 7.5). 
3. 200 µM Ferricytochrome C:  Dissolve 2.5 mg ferricytochrome C (horse heart) in 1 
ml of 50 mM potassium phosphate buffer (pH 7.5). 
4. 100 mM o-aminobenzaldehyde: Dissolve 24.2 mg o-aminobenzaldehyde in 0.842 
ml of 95% ethanol. Add 1.158 ml H2O, and mix. 
Assay procedures 
1.  To each tube, add the following: 
 0.5 ml of 30 mM proline  0.1 ml of 200 μM ferricytochrome C 
 0.1 ml of sonicated mitochondria suspension 
 0.3 ml of 50 mM potassium phosphate buffer (pH 7.5) 
 (Blanks: All above components, but 0.5 ml of 10% TCA is added to the assay 
mixture before addition of 0.1 ml mitochondrial suspension.) 
2. Incubate the assay mixture at 37oc for 30 min. 
3. Add 0.5 ml of 10% TCA to terminate the reaction. (Note that blanks are already 
acidified with 10% TCA before addition of cell extracts.) 
4. Add 0.1 ml of 100 mM o-aminobenzaldehyde to the acidified solution. Mix.   
5. After 30 min, centrifuge the solution at 600 g for 5 min. Measure the absorbance of 
the supernatant fluid at 440 nm. 
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Calculation: 
Molar extinction coefficient of POX at 440 nm = 2.7x103/M.cm 
Total volume of the solution: 1.6 ml. 
 
  
 131 
 
A6 Pyruvate Assay Using Fluorometric Method 
 
Chemicals. 
1. 150 mM Phosphate buffer (pH 7.5): Dissolve 10.2 g KH2PO4 in 450 ml H2O.  Adjust 
the solution to pH 7.5 with 10 M KOH, and makeup to a final volume of 500 ml 
with H2O. 
2. β-NADH solution: 
 a) 1 mM NADH: Dissolve 7.1 mg ß-NADH-Na2 (Boehringer Mannheim, Cat # 128-
023) in 10 ml of 150 mM phosphate buffer (pH 7.5).   
 b) 50 μM NADH: Dilute 0.5 ml of 1 mM NADH to 10 ml with 150 mM buffer.   
3. Pyruvate standard: 
 a) 5 mM Pyruvate: Dissolve 55 mg sodium pyruvate in 100 ml H2O.  
 b) 50 μM Pyruvate: Dilute 0.1 ml of 5 mM pyruvate to 10 ml with H2O. 
 
4. L-Lactate dehydrogenase from beef heart. 
 
Assay Procedures. 
1. To each tube, add the following: 
 0.2 ml of Pyruvate standard/Sample 
 0.15 ml of 50 μM NADH 
 1.5 ml of 150 mM Phosphate buffer (pH 7.5)   
2. Mix well.  After 2 min, read fluorescence F1 (Excitation 340 nm, Emission 460 nm). 
3. Add 5 μl L-lactate dehydrogenase into each tube.  Mix well.  After 5 min, 
  read fluorescence F2 (Excitation 340 nm, Emission 460 nm). 
